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ABSTRACT The ruthenium-catalyzed azide alkyne cycloaddition (RuAAC) affords 1,5-
disubstituted 1,2,3-triazoles in one step and complements the more established copper-catalyzed 
reaction providing the 1,4-isomer. The RuAAC reaction has quickly found its way into the 
organic chemistry toolbox and found applications in many different areas, such as medicinal 
chemistry, polymer synthesis, organocatalysis, supramolecular chemistry and the construction of 
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electronic devices. This review discusses the mechanism, scope and applications of the RuAAC 
reaction, covering the literature during the last 10 years. 
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1. INTRODUCTION 
Nitrogen-containing heterocycles are ubiquitous in nature, being components of many important 
biomolecules such as RNA and DNA, peptides and proteins, vitamins and co-factors, and found 
in natural products such as alkaloids. Due to the diversity of properties displayed by nitrogen 
heterocycles, members of this class such as triazoles are widely applied in the pharmaceutical 
industry,
1-2
 and synthetic methods for these building blocks are thus of importance. This review 
will focus on 1,2,3-triazoles. While earlier methods for preparing these molecules often required 
harsh reaction conditions,
3
 this changed in 2002 when Meldal as well as Fokin and Sharpless 
independently reported mild and direct methods for accessing 1,4-disubstituted 1,2,3-triazoles in 
one step from an organic azide and an alkyne, using Cu(I)-catalysis.
4-5
 This copper-catalyzed 
azide alkyne cycloaddition (CuAAC) has since found widespread use even outside the chemistry 
community.
6-11
 However, a method to form the corresponding 1,5-disubstituted 1,2,3-triazole 
isomer was also needed. In 2005 this problem was solved by Fokin and Jia,
12
 who showed that 
by exchanging copper for ruthenium, this class of isomers could also be accessed. While this 
ruthenium-catalyzed azide alkyne cycloaddition (RuAAC) has as yet not found as prevalent use 
as the CuAAC reaction, reports of its application are increasing rapidly. Although, the RuAAC 
reaction has been briefly mentioned in several reviews on triazole formation
13-23
 and metal-
catalyzed reactions,
24-26
 by now a comprehensive survey focused solely on RuAAC is needed. 
This review covers the initial reports of the ruthenium-catalyzed azide alkyne cycloaddition from 
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2005
12
 and 2008,
27
 as well as the synthetic development, mechanistic studies and applications of 
the RuAAC reaction up until September 2016. 
 
2. BACKGROUND 
The 1,3-cycloaddition of organic azides to alkynes to form 1,2,3-triazoles is generally referred 
to as the Huisgen cycloaddition, due to Huisgen’s extensive studies of the mechanism and 
kinetics of dipolar cycloadditions in the 1960s.
28-30
 The first report of such a transformation dates 
back even further, to 1893, when Michael described the reaction of phenyl azide with dimethyl 
acetylenedicarboxylate.
31
 However, many cycloadditions involving azides are impractically slow 
at ambient temperature,
32
 and mixtures of 1,4- and 1,5-disubstituted triazoles are formed in the 
reaction with alkynes (Scheme 1).
28
 
Scheme 1 The thermal cycloaddition of organic azides with alkynes affords isomeric 
mixtures
28,33
 
 
In 2002, both Meldal at the Carlsberg Laboratory in Copenhagen,
4
 as well as Fokin and 
Sharpless at the Scripps Research Institute in La Jolla,
5
 independently reported that Cu(I) can 
catalyze the 1,3-cycloaddition of alkynes to organic azides to selectively form 1,4-disubstituted 
1,2,3-triazoles under mild reaction conditions. Meldal applied this reaction towards the solid 
phase synthesis of triazole-based peptidomimetics, using copper(I) iodide as the catalyst.
4
 The 
report from Scripps, meanwhile, provides a procedure for the reaction in solution, employing 
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convenient in situ reduction of copper(II) sulfate with ascorbic acid to form the necessary Cu(I) 
species.
5
 This Cu-catalyzed azide alkyne cycloaddition (CuAAC) has since been applied to a 
great extent,
9-11,34-35
 not only in chemistry but also in related areas such as biology
36-38
 and new 
materials,
39
 mainly due to the experimental simplicity of the reaction, as well as its robustness 
and the high yields obtained. The reaction is tolerant to almost every functional group, can be 
performed in a wide range of solvents, including water, and has a very favorable atom 
economy
40
 as all ingoing components are, at least in theory, incorporated into the product. 
Triazoles are stable compounds with interesting properties,
1
 but an important application of this 
reaction has also been as a method for connecting or ‘clicking together’ two molecules with each 
other, providing an alternative to amide bond formation which has traditionally filled this role. 
Although ‘click chemistry’ in the original definition,41 includes a wider range of 
transformations,
42-43
 CuAAC is normally the first reaction that springs to mind when this 
expression is employed.
44
 
As mentioned, different isomers can be obtained in the cycloaddition of alkyl and aryl azides 
with alkynes. While the original Huisgen reaction afforded mixtures of 1,4- and 1,5-disubstituted 
1,2,3-triazoles,
32
 and CuAAC selectively produced the 1,4-isomer,
4-5
 there was a lack of robust 
methods for the exclusive formation of 1,5-disubstituted triazoles. Such compounds can be of 
interest in their own right, as the positioning of the two substituents on adjacent atoms can be 
advantageous in cyclization reactions, and the rigid cyclic structures of these products exploited 
in materials science applications. However, in many of the studies discussed in this review, the 
main focus has been to compare the properties of 1,4- and 1,5-disubstituted 1,2,3-triazoles in 
different contexts, and this is especially true in the area of medicinal chemistry and studies of 
bioactive compounds. 
 7 
In looking at methods for the preparation of 1,5-triazole isomers, selected metal acetylides (Sn, 
Ge, Si, Na) had early on been reported to produce 4-metalated 1,5-disubstituted triazoles,
45-46
 and 
Akimova studied the reactions of lithium and magnesium acetylides in detail in the 1960s.
47-49
 
These latter reactions are proposed to involve nucleophilic attack of the lithium or magnesium 
acetylide on the azide followed by ring closure to form metallotriazole 1 (Scheme 2). Quenching 
of the reaction then afforded the 1,5-disubstituted 1,2,3-triazole 2. However, the yields were low 
and the reaction was accompanied by the formation of by-products. 
Scheme 2.  Proposed mechanism for triazole formation using Li and Mg acetylides
47-50
 
 
Krasiński, together with Fokin and Sharpless, returned to these early reports by Akimova to see 
if the magnesium-mediated reaction could be improved.
50
 They found that the original procedure 
described by Akimova provided 1,5-disubstituted 1,2,3-triazole 2 in substantially higher yields 
than earlier reported (Scheme 3). In addition, the scope of substrates applied in the reaction was 
increased. The 4-metalated triazole intermediate could also be trapped with other electrophiles 
than protons, providing access to 1,4,5-trisubstituted 1,2,3-triazoles 3. 
Scheme 3.  1,5-Disubstituted and 1,4,5-trisubstituted 1,2,3-triazoles from magnesium 
acetylides
50
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However, the use of magnesium acetylides requires stoichiometric amounts of metals and such 
reagents are incompatible with a number of functional groups. A catalytic alternative to CuAAC 
that provides access to 1,5-disubstituted 1,2,3-triazoles would be preferable. As Ru(II) is known 
to catalyze reactions involving alkynes,
51
 Fokin and Jia reasoned that a ruthenium(II) complex 
could perhaps be applied towards the synthesis of 1,2,3-triazoles via a cycloaddition reaction 
using an alkyne in a similar manner to the CuAAC reaction.
12
 Initial catalyst screening, using the 
reaction of benzyl azide with phenylacetylene as a test system, showed that triazoles were indeed 
formed when heating all components in benzene at 80 °C for 4 hours. Complexes such as 
Ru(OAc)2(PPh3)2, RuCl2(PPh3)3 and RuHCl(CO)(PPh3)3 afforded the 1,4-disubstituted 1,2,3-
triazole (4, Scheme 4) with varying degrees of conversion, and this type of selectivity is 
discussed in more detail in section 4.5.2. However, a complex containing a cyclopentadienyl 
ligand, CpRuCl(PPh3)2, did encouragingly produce the 1,5-isomer 5, albeit accompanied by 
some of the 1,4-disubstituted derivative. By switching to the more sterically hindered 
pentamethylcyclopentadienyl derivative Cp*RuCl(PPh3)2, complete selectivity for the 1,5-
disubstitued triazole was obtained. Several other Ru(II) catalysts containing the [Cp*RuCl] unit 
were also useful in effecting this transformation, i.e. Cp*RuCl(COD) (COD = cyclooctadiene), 
 9 
Cp*RuCl(NBD) (NBD = norbornadiene) as well as [Cp*RuCl2]2. A full investigation of the 
scope and limitations of this reaction was then carried out as part of this initial report
12
 as well as 
in an ensuing publication a few years later, where also RuH2(CO)(PPh3)3 was reported to afford 
the 1,4-regioisomer.
27
 Certain aspects of these initial studies, concerning the substrate scope as 
well as the catalysts that have been evaluated, are covered in more detail in other sections below, 
but a summary of these two seminal papers will be given here.  
Scheme 4. Regiochemical outcome using different Ru-catalysts
12
 
 
Conditions: 5 mol% catalyst, benzene, 80 °C, 4 h. Reactions with Ru(OAc)2(PPh3)2, 
RuHCl(CO)(PPh3)3 and CpRuCl(PPh3)2 afforded low yields. 
The initial conditions employed 5 mol% catalyst, but this could be reduced to 1 mol% in most 
cases. Heating to 60-80 °C did provide a more rapid reaction for Cp*RuCl(PPh3)2, but ambient 
temperature could be applied by running the reaction for longer time at higher catalyst loading. 
For the more reactive complex Cp*RuCl(COD), the reaction gave high yields at room 
temperature even after 30 minutes. Both polar and non-polar solvents could be employed, 
including benzene, toluene, dioxane, tetrahydrofuran, dimethylformamide and 1,2-
dichloroethane. Yields were substantially lower if the reaction was performed in protic solvents 
such as water and alcohols, but trace amounts of water in non-protic solvents did not affect the 
reaction. As oxygen may react with the Cp*RuCl(COD) catalyst, it is recommended to perform 
reaction under an inert atmosphere in this case to avoid degradation of the complex.
52
 However, 
the Cp*RuCl(PPh3)2 catalyst did not appear to be very sensitive in this system, and excellent 
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conversions were obtained even if oxygen was not excluded.
27
 A striking feature of the reaction 
is the high tolerance towards many functional groups, such as alkyl and aryl chlorides, boronic 
ester, alkenes and polyalcohols, in both the azide and the alkyne reaction partners. Fig. 1 shows 
some of the products formed using either Cp*RuCl(PPh3)2 or Cp*RuCl(COD) as the catalyst.  
Figure 1.  Selected products from the original reports of the RuAAC reaction.
12,27
  
 
In contrast to the CuAAC reaction, which is limited to terminal alkynes, the RuAAC reaction 
was found to tolerate internal alkynes, providing access also to 1,4,5-trisubstituted 1,2,3-
triazoles.
12,27
 The Cp*RuCl(COD) catalyst was found to be well adapted to this task, allowing 
reactions to be performed at ambient temperature in order to access a wide range of different 
trisubstituted alkynes. This aspect of the reaction, as well as the observed regiochemistry for this 
class of alkyne substrates, is discussed in more detail in chapter 4.4.2. The reactivity of internal 
alkynes is also an indication that the reaction does not proceed via a ruthenium acetylenide, in 
contrast to the CuAAC reaction that involves an intermediate copper acetylenide.
53
 Mechanistic 
proposals for this reaction are summarized in the next chapter. 
 
3. MECHANISTIC AND THEORETICAL STUDIES 
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Regarding the mechanism of triazole formation, numerous studies have appeared, addressing the 
reaction steps throughout the cycloaddition. These rely on both experimental techniques, 
employing e.g. mass spectrometry, NMR spectroscopy, and single crystal X-ray diffraction, as 
well as on quantum mechanical (QM) calculations using mainly density functional theory (DFT). 
We here mostly focus on the Ru-catalyzed azide alkyne cycloaddition, for studies on the Cu-
catalyzed azide/alkyne1,3-cycloaddition reaction (CuAAC) the reader is directed to papers by 
Rostovtsev et al. and Himo et al.
5,53
 Note, that other transition metal complexes can be used in 
the chemistry of organic azides, these reactions are covered in a detailed review by Cenini et al.
54
 
The atomic level insight by computations into the chemical reorganization provides an important 
contribution in understanding the steric and energetic aspects of the reaction. However, 
calculations quite often provide several alternative routes, where it is not trivial to select the most 
likely reaction pathway. Furthermore, the accuracy of energetic descriptions can often be 
undermined due to solvent effects, temperature, and other parameters. Consequently, capturing 
key intermediates and determining conversion rates by experimental methods provide important 
contributions to selecting the most probable reaction mechanism. Accordingly, in this section we 
concentrate on the steric and energetic details of the Ru-catalyzed cycloaddition provided by 
theoretical methods, but we reflect also on their correlation with experimental investigations. 
The general mechanism of the azide alkyne 1,3-cycloaddition reaction (AAC) has been 
described in the early study by Himo et al.
53 
The authors employed the B3LYP hybrid functional 
and considered the cycloaddition for both 1,4- and 1,5-regioisomers.
53
 The reaction without any 
catalyst has a rather high barrier for both 1,4- and 1,5-regioisomers, with a relative energy of 
25.7 and 26.0 kcal/mol respectively. Both reaction pathways were reported to be highly 
exothermic with over 60 kcal/mol, not accounting for entropy effects.
27,53
 The general 
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mechanism was further investigated by Houk et al. who addressed substituent effects in detail 
and also the reversibility of the 1,3-dipolar cycloadditions involving azides and either alkenes or 
alkynes.
55
 Houk employed complete basis set calculations (CBS), which allow energetic 
predictions with very high accuracy.
56
 Their results indicated that azide 1,3-dipolar 
cycloadditions with alkenes and alkynes have similar reaction barriers, but for the latter the 
products are more exothermic by ~30-40 kcal/mol. They also concluded that azide 
cycloadditions with alkynes and most alkenes are irreversible. Note that the calculations also 
provided the single, so far only theoretical, prediction that the reaction of methanesulfonylazide 
with N,N
’
-dimethylvinylamine may be reversible at micromolar reactant conditions. 
Focusing more on the ruthenium catalysts, Boren et al. employed DFT calculations using 
methyl azide and propyne as model reactants with [CpRuCl].
27
 These calculations demonstrated 
that in principle four different relative orientations are possible for the methyl azide and propyne, 
with rather small relative energy differences between them (Fig. 2).
27,57 
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Figure 2. The four possible orientations of the reactants in their initial complexes. Structures are 
reproduced from original optimized coordinates provided by the authors.
27
 
 
Although two of these alternative orientations would eventually lead to 1,4-regioisomers, three 
pathways were ruled out either due to much higher barrier heights or due to steric repulsions in 
the product states. The lowest energy pathway had its highest barrier at 13 kcal/mol, much lower 
than the barrier height for the same path without a catalyst. This shows that Ru is an efficient 
catalyst, reducing the rate of the reaction by several orders of magnitude. The calculated results 
(Fig. 3) fit well to the experimental observations, explaining the 1,5-regioselectivity and also 
providing a reasonable energetic explanation for the reaction rate. The reaction was later 
revisited in detail by using alternative substrates including Cp
*
, which confirmed the reaction 
paths determined earlier, but further explained the effect of different substituents on the reaction 
rate and the product ratio of 1,4- and 1,5-regioisomers.
58
 Based on the results, Boren et al. 
proposed that the mechanism involves an irreversible oxidative coupling, which is a nucleophilic 
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attack of the coordinated alkyne on the terminal electrophilic nitrogen of the azide, and this is 
followed by a reductive elimination.  
Figure 3. Simplified schematics of the reaction pathway obtained for the lowest energy pathway 
using DFT calculations.
27
 Structures were reproduced from optimized coordinates provided by 
the authors, relative energies are in kcal/mol. 
 
The mechanism was also addressed by Hou et al.,
59
 who again confirmed the irreversibility of 
the reaction, and further investigated the molecular orbitals of the C-N bond forming transition 
state using DFT calculations and Bader’s atoms in molecules theory.60-61 The latter analyzes 
interactions of atoms by topological mapping of the surrounding electron density. They found 
that when using larger substrates, the transition state involves the electron donation from the 
alkynyl carbon to the * orbital of the N=N group from the azide, opening the way to formation 
of a transient cyclic structure where the  electrons delocalize from the alkynyl to the azido 
group. It is worth noting that for internal alkynes, both Tüzün58 and Hou59 showed a higher 
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energy transition state for the C-N bond forming step than observed initially for small substrates 
and terminal alkynes. 
Besides 1,5-substituted 1,2,3 triazoles, selective synthesis of 1,4-substituted compounds can 
also be achieved with high yield using Ru complexes lacking Cp ligands (see section 4.5.2). Liu 
et al. have demonstrated that among other catalysts, RuH(BH4)(CO)(PCy3)2 and 
Ru(C≡CPh)2(CO)(PCy3)2 were the most active.
62
 In addition to mass spectrometry, X-ray 
diffraction and NMR spectroscopy, the authors have also used DFT calculations to elucidate the 
mechanism of the reaction. The presence of the triazolide intermediate (structure provided by X-
ray, Fig. 4) indicates that the Ru center actively takes part in the reaction, forming even a Ru
…
H-
C interaction with one hydrogen of the CMe3 group in the triazolyl ligand.
62
  In their DFT studies 
using methyl azide and propyne as model substrates, the authors have determined that the 
reaction starts with a Ru complex which coordinates the internal nitrogen in the azide. The 
triazolide intermediate is then reached via a metathesis step, which is also the rate determining 
step at 11.5 kcal/mol. The pathway for these complexes lacking Cp ligands to 1,5-disubstituted 
products has a much higher barrier, 21.5 kcal/mol, which explains their selectivity towards 1,4-
disubstitution. The structural explanation is that coordination of the internal (-N-Me) nitrogen 
from the azide on the Ru complex results in an intermediate and a transition state with 
conjugated bond systems, thus the barrier of the TS for the rate determining step lowers 
significantly. In contrast to Cp-containing Ru catalysts, the final Ru complex with the formed 
triazole product has a much lower energy gain with a -38.6 kcal/mol relative energy. In overall, 
the lowest energy reaction pathway for the Ru complexes lacking Cp ligands is rather similar to 
those with a Cu catalyst. 
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Figure 4. Structural evidence for the formation of a triazolide intermediate in the reaction of 
benzyl azide with Ru(C≡CCMe3)2(CO)(PPh3)3. Reproduced from Liu, P. N.; Li, J.; Su, F. H.; Ju, 
K. D.; Zhang, L.; Shi, C.; Sung, H. H. Y.; Williams, I. D.; Fokin, V. V.; Lin, Z. Y.; Jia, G. 
Selective Formation of 1,4-Disubstituted Triazoles from Ruthenium-Catalyzed Cycloaddition of 
Terminal Alkynes and Organic Azides: Scope and Reaction Mechanism. Organometallics 2012, 
31, 4904-4915. Copyright 2012 American Chemical Society. 
 
To provide a systematic overview on alternative Ru complexes, Nolan et al. have investigated 
the effect of substituents in Ru complexes that result in unsaturated 16-electron configurations in 
the general form of Cp*Ru(L)Cl.
63
 Here L was a sterically demanding ligand, either phosphine 
or an N-heterocyclic carbene (NHC), where the nitrogens contained adamantyl- (IAd), 
diisopropyl- (IPr) or cyclohexyl groups (ICy).
63
 They chose sterically large substrates to model 
the reaction, using benzylazide and phenylacetylene to afford the 1,5-disubstituted 1,2,3-triazole 
compound. Mechanistic insights were gained by NMR experiments combined with DFT 
calculations. Catalysts with phosphines, Cp*Ru(PiPr3)Cl and Cp*Ru(PCy3)Cl, showed the best 
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catalytic activity having an 89% and 87% conversion rate respectively, while the best catalyst 
with an NHC-based ligand was IAd, showing a somewhat lower conversion of 67%. In terms of 
mechanism, this clearly hints that the behavior of the Ru complexes cannot be directly correlated 
to the steric size of the L ligands. The authors have also demonstrated that the anionic Cl ligand 
makes an important contribution to the conversion rate.
63
 While Cp*Ru(PiPr3)Cl had a rate of 
89%, the alkoxo complex Cp*Ru(PiPr3)(OCH2CF3) produced only traces of the product. They 
have also found that addition of the alkyne prior to addition of the azide lowered the conversion 
by sixfold, whereas adding the azide first and the alkyne as second did not show any significant 
difference relative to adding the mixture of the two substrates. In line with the above, the 
calculations have shown that excess phenylacetylene results in a complex with two alkyne 
ligands on the Ru complex leading to the production of a 1,4 disubstituted metallacycle as 
predicted earlier.
64
 A similar scenario was also investigated using excess phenyl azide, which 
could potentially lead to a stable tetraazametallacyclopentene ring. However, the highest barriers 
are rather low while for the former, below 10 kcal/mol, while several barriers are well above 20 
kcal/mol in the latter case. These give an explanation for the experimental behavior of the 
studied Ru complex in excess of one of the substrates. In contrast to the species based on 
[Cp*RuCl], here the extrusion of ligands to create the coordinative unsaturation at the Ru center 
is of importance. The calculations have demonstrated that out of the activated catalysts having 
the original Cp*Ru(PiPr3)Cl and either phenylacetylene, or the internal- or terminal N-
coordinated benzylazide, only the Cp*RuCl(-HCCPh)-(PiPr3) complex favors phosphine 
dissociation over that of the bound substrate. This is also in agreement with the NMR studies 
which observed this intermediate complex at low temperatures. These results suggest that 
activation of the catalyst should proceed through initial coordination of an alkyne substrate, and 
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thus alkyne binding precedes azide coordination. Starting from the activated catalyst, the reaction 
for the investigated complex then progresses on the same pathway as observed by Boren et al.
27
 
 
4. METHODOLOGY, SUBSTRATES AND CATALYSTS 
This chapter will look at the general conditions that can be applied for the RuAAC reaction, 
summarize the catalysts that have been employed in different studies, as well as report on more 
specialized studies where the focus has been on the reaction itself rather than on the applications 
of the target molecules. 
 
4.1. General Methodology 
A typical RuAAC procedure involves the reaction of an alkyne with an organic azide in the 
presence of catalytic amounts of a ruthenium(II) complex containing a [Cp*RuCl] unit in a non-
protic solvent. A variety of solvents can be used for the reaction, where the most commonly used 
are aromatic solvents like benzene or toluene, or ethers such as THF and dioxane. Certain polar 
solvents can also be applied, i.e. DMF and DMA, while reactions using DMSO have been 
reported to be problematic,
65
 which is most likely related to the ability of DMSO to act as ligand 
to ruthenium.
66
 Protic solvents are not suitable, giving low yields and a high degree of byproduct 
formation.
27,52
 Most reported RuAAC reactions employ either Cp*RuCl(PPh3)2 or 
Cp*RuCl(COD) as the catalyst, using between 1 and 5 mol% catalyst, and both these complexes 
are commercially available. For full details of the catalyst scope, see section 4.5. Although 
heating is generally employed to shorten reaction times, reactions at ambient temperature are 
also possible, especially when using a catalyst with high reactivity such as Cp*RuCl(COD).
27
 A 
typical procedure for the RuAAC reaction has been described by Oakdale and Fokin in Organic 
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Synthesis and involves the reaction of benzyl azide with phenyl acetylene in dichloroethane at 45 
°C, using 1 mol% Cp*RuCl(COD) as the catalyst.52 The high tolerance to a wide range of 
functional groups has already been mentioned in chapter 2; these include alcohols and polyols, 
amines and pyridines, alkyl and aryl halides, ethers, aldehydes and ketones, esters, amides, 
sulfonamides, carbamates and boronic esters.
12,27
 However, acidic functionalities such as 
carboxylic acids, boronic acids and HCl/HBr salts of amines can be problematic.
65
 This broad 
application scope is also one of the reasons why the RuAAC reaction has been extensively 
applied in the area of medicinal chemistry, where highly functionalized substrates, often 
including H-bond donors and acceptors, are used. Such applications are covered in more detail in 
chapter 5. 
The use of microwave heating has been applied in several instances in the CuAAC reaction to 
accelerate triazole formation,
67-68
 but is of even more relevance for the RuAAC reaction where 
heat is in many cases required to achieve a high conversion in a short time. Fokin and co-workers 
applied this technology in the RuAAC reaction when investigating aryl azides as substrates (see  
chapter 4.3).
69
 The authors reportedly opted for a microwave-mediated reaction to facilitate 
optimization of the reaction conditions, but also found that direct comparison of a microwave-
assisted reaction with conventional oil bath heating was in favor of the former (Scheme 5). Not 
only was the yield higher when microwave heating was used, but the conventional method was 
also fraught with byproduct formation. Looking at other comparisons between conventional and 
microwave heating, Carvalho et al. also reports a higher yield employing microwave assisted 
RuAAC in their synthesis of benznidazole analogues,
70
 of interest for the treatment of Chagas 
disease. However, Agrofoglio and colleagues obtained similar results in terms of yield and 
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selectivity when comparing oil bath heating with microwave heating in the synthesis of ribavirin 
analogues via RuAAC.
71
 The reaction time was significantly shortened, however. 
Scheme 5. Comparison of microwave and conventional heating
69
 
 
A sequential microwave-assisted one-pot method to produce triazoles directly from alkyl 
halides, more easily available than alkyl azides, was described by Johansson et al.
65
 Although 
direct one-pot methods for CuAAC have been reported,
72-74
 only trace amounts of product were 
formed when a solution of benzyl bromide, sodium azide, 3-ethynylpyridine and 
Cp*RuCl(PPh3)2 in DMA were subjected to microwave heating at 100 °C for 30 min. Catalyst 
deactivation or competing reactions are most likely the cause here.
75-76
 However, by first heating 
the alkyl halide with sodium azide for 10 min and then adding the catalyst and the alkyne 
(Scheme 6), this problem was solved and 14 different triazoles were prepared in moderate to 
excellent yields. Alkyl chlorides as well as iodides could also be used, while acidic 
functionalities in the alkyne or alkyl halide were not tolerated. 
Scheme 6.  Microwave-assisted sequential one-pot RuAAC using alkyl halides as precursors
65
 
 
4.2.  Structural Assignment 
Once the triazole is formed, suitable analytical methods are needed to determine the 
regioselectivity in the reaction and to confirm that the 1,5-disubstituted isomer is indeed the one 
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formed, as the 1,4- and 1,5-isomers are difficult to differentiate between using simple 
1
H NMR. 
In the original report by Fokin and Jia, the structure and 1,5-regioselectivity of selected products 
were verified by X-ray crystallography (see Fig. 5).
12
  
Figure 5. Confirmation of the 1,5-regioselectivity using X-ray diffraction: 1,2,3-triazole 
formed in the reaction between benzyl azide and a propargylic alcohol. Adapted from Zhang, L.; 
Chen, X. G.; Xue, P.; Sun, H. H. Y.; Williams, I. D.; Sharpless, K. B.; Fokin, V. V.; Jia, G. C. 
Ruthenium-Catalyzed Cycloaddition of Alkynes and Organic Azides. J. Am. Chem. Soc. 2005, 
127, 15998-15999. Copyright 2005 American Chemical Society. 
  
 
1D or 2D NMR techniques based on the nuclear Overhauser effect (NOE), providing information 
on interactions through space, rather than through bonds, are also convenient tools to 
differentiate between the 1,4- and 1,5-isomers and have been applied in several instances.
65,77
 
Creary et al. sought to develop a simpler means of distinguishing between the 1,4- and 1,5-
isomer of a 1,2,3-triazole using 
13
C NMR.
78
 19 pairs of triazole isomers bearing a variety of 
different substituents were investigated, focusing on the signal displayed by the unsubstituted 
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carbon of the triazole ring. As a general trend, the C5 carbon of the 1,4-disubstituted triazole 
displays a signal around 120 ± 3 ppm, while the corresponding C4 carbon of the 1,5-
disubstituted isomer instead appears around 133 ± 3 ppm (Fig. 6). For triazoles carrying a 
carbonyl group, the signals from the unsubstituted carbons are shifted slightly, but nevertheless 
show a clear difference between the two isomers. Ethoxy-substituted isomers also deviated from 
the norm, with carbon signals for the unsubstituted carbons appearing at 106 ppm for the 1,4-
isomer and 114 ppm for the 1,5-isomer. Both these discrepancies are in line with predictions 
obtained via supportive theoretical studies. The authors employed DFT calculations and used 
Gauge-Independent Atomic Orbitals (GIAO) to calculate the shielding tensors for the 
investigated compounds. Though having a consistent 6 ppm upfield shift compared to the 
experiments, the theoretical calculations showed the same relative differences for C4 and C5 as 
in the experiments. 
Figure 6. 
13
C NMR as a tool for distinguishing between 1,4- and 1,5-disubstituted 1,2,3-triazole 
isomers.
78
 
 
The heterocyclic ring of triazoles contains three nitrogen atoms that could potentially also be 
analyzed using NMR. The low natural abundance and sensitivity of 
15
N has earlier been a 
limitation in applications of 
15
N NMR spectroscopy, although probe development and new pulse 
techniques have greatly facilitated the use of this technology.
79
 Alfonso and coworkers
80
 instead 
applied an indirect method, i.e. a gradient enhanced indirect detection pulse sequence,
81
 that 
makes use of the 
1
H nucleus to obtain information about 
15
N NMR shifts in order to differentiate 
between 1,4- and 1,5-disubstituted 1,2,3-triazole isomers, as well as to distinguish these from the 
less common 2,4-disubstituted isomer. The substituted nitrogen appears at a much lower shift (in 
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the range of −120 to −140 ppm) in comparison to the other two nitrogen atoms for all three 
isomers, allowing the 2,4-substituted isomer to be easily identified. The 
1
H/
15
N correlation 
pattern can then be employed to distinguish the 1,4- and 1,5-disubstituted isomers. To aid 
interpretation of the experimental results, the GIAO method mentioned above was used with 
DFT calculations. To reach a consistent dataset, the authors have calculated the shielding value 
for all obtained conformers and used a Boltzmann weighing based on the relative energies of 
these different conformers. These data showed reasonable agreement with the NMR results and 
helped differentiating between the different observed isomers. 
 
4.3. Azides 
The highly energetic nature of azides as well as their toxicity are aspects that need to be 
considered when working with 1,3-cycloaddition reactions of azides to alkynes, and we 
recommend new users of the CuAAC and RuAAC reactions to familiarize themselves with the 
properties of azides before embarking upon experimental work. A treatise by Keicher and 
Löbbecke on the safety of azides provides some general guidelines.82 As a rule of thumb, azides 
with a (C+O)/N ratio of less than 3 are considered to be highly explosive. 
In the initial report of the RuAAC reaction, Fokin and Jia reported that some limitations were 
found in terms of the azide component.
12
 Although primary aliphatic azides functioned well in 
the reaction, both tertiary azides (tert-butyl and adamantyl) as well as aromatic azides, afforded 
low yields. Reactions of the latter were also accompanied by the formation of byproducts. An 
exception was seen in the reaction of 1-azido-4-methoxybenzene with a tertiary propargylic 
alcohol, forming the desired triazole in 94% yield. Reactions involving sterically hindered azides 
could be improved by increasing the catalyst loading to 5% and extending the reaction time. 
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Seeking to find a solution also to the problematic aryl azides, Fokin and co-workers investigated 
other ruthenium catalysts to see if a more efficient conversion to 1-aryl-substituted 1,2,3-isomers 
could be attained.
69
 During the initial development of the RuAAC reaction, the authors had 
found that the ruthenium tetramer [Cp*RuCl]4 performed well in RuAAC reactions of aliphatic 
azides with alkynes using dimethylformamide as the solvent.
69
 This catalyst, prepared by 
reduction of [Cp*RuCl2]n with LiBHEt3, was thus evaluated with aryl azides and was indeed 
found to effect the desired transformation efficiently. Microwave irradiation was employed to 
facilitate optimization of the reaction, and suitable conditions involved the use of 10 mol% 
catalyst in DMF, heating for 20 min at 110 ºC (Scheme 5). Longer reaction times did not provide 
a higher yield, indicating that catalyst deactivation is a competing reaction. Both electron rich 
and electron poor aryl azides could be employed (Scheme 7), although the authors report that 
strongly electron-withdrawing groups as well as diortho substituents inhibited the reaction. 
Scheme 7. Improved conditions for aryl azides in RuAAC using microwave heating
69
 
 
The remainder of this section will look at two reports where focus has been on the azide 
component. -Tosylethylazide can be employed as a synthon for hydrazoic acid, HN3, in the 
RuAAC reaction to access 5-substituted 1H-1,2,3-triazoles after deprotection (Scheme 8), as 
shown by Yap and Weinreb.
83
 Phenylacetylene was heated with an excess of -tosylethylazide in 
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the presence of Cp*RuCl(PPh3)2, using benzene as the solvent, affording selectively the 1,5-
disubstituted triazole 6 in 77% yield. Deprotection of the -tosylethyl group with potassium tert-
butoxide in THF at low temperature produced the free 1H-1,2,3-triazole 7 via a retro-Michael 
reaction, providing convenient access to this class of substrates. Internal alkynes were also 
applicable in this reaction. The -tosylethylazide reagent was prepared in one step from 
commercially available p-tolyl vinyl sulfone and sodium azide, and could be stored at low 
temperature for an indefinite period of time. 
Scheme 8. A 5-substituted 1H-1,2,3-triazole from a -tosylethyl-protected azide83 
 
Fused tetrazoles can be applied as azide surrogates in CuAAC reactions with alkynes to form 
1,4-disubstituted triazoles appended with a heterocyclic functionality such as a 2-pyridyl moiety, 
as demonstrated by Gevorgyan and co-workers.
84
 The reaction is based on the equilibrium 
existing between the closed form of the tetrazole and the corresponding open azide form 
(Scheme 9a), where the position of this equilibrium can depend on a variety of factors, including 
the substitution pattern and the reaction conditions. Attempted cyclization of phenylacetylene 
with tetrazole 8 using Cp*RuCl(PPh3)2 was unsuccessful, however (Scheme 9b). The authors 
speculated that the nitrogen atom of the pyridine could be involved in chelation with the 
ruthenium complex, resulting in catalyst deactivation. A reaction using 4-azidopyridine, where 
such chelation is not possible, afforded mainly the 1,5-disubstituted product indicating that it is 
indeed the positioning of the 2-azide functionality relative to the pyridine nitrogen that is the 
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problem. This convenient azide surrogate methodology is thus unfortunately not applicable in 
RuAAC. 
Scheme 9. Attempted use of a fused tetrazole as a 2-azidopyridine surrogate
84
 
 
 
4.4. Alkynes 
A wide scope of alkynes are compatible with the RuAAC reaction, including also internal triple 
bonds and alkynes directly connected to a heteroatom. Many of the terminal alkynes employed in 
RuAAC belong to the category functionalized terminal alkynes and the majority of these alkynes 
have in this review been classified according to the potential applications of the triazoles 
produced. In this section, we will discuss various functionalized alkynes where method 
development has been the focal point of the study. 
4.4.1. Functionalized Terminal Alkynes. 
Farooq and colleagues have investigated terminal alkynes with oxygen functionalities on both 
the - and -carbons in both CuAAC and RuAAC, with the aim of producing 1,2,3-triazoles 
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with polar substituents for applications in the area of peptidomimetics.
85
 Ketal 9 as well as 
ketone 10 were selected as substrates and reacted with benzyl azide in the presence of CuSO4 to 
form triazoles 11 and 12 via CuAAC (Scheme 10). Disappointingly however, treatment of ketal 
9 with Cp*RuCl(PPh3)2 afforded only recovered starting materials upon workup. Ketone 
substrate 10 did react, but produced not a triazole but instead the aromatic product 13, which the 
authors propose is formed via an ionic cyclotrimerization reaction. The same group have also 
investigated the debenzylation of N-benzylated 1,4- and 1,5-disubstituted 1,2,3-triazoles under 
hydrogenation conditions, showing that both isomers afford the same 1H-1,2,3-triazole via 
tautomerization of the product.
86
  
Scheme 10. CuAAC and attempted RuAAC using highly functionalized alkynes
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Piperidines are common motifs in natural products as well as in pharmaceuticals. Haug and 
colleagues prepared a set of 3-hydroxypiperidine triazoles using both CuAAC and RuAAC.
87
 
1,5-Disubstituted triazoles 14 and 15 were successfully synthesized from alkynes 16 using 1 
mol% of Cp*RuCl(PPh3)2 as the catalyst (Scheme 11).  
Scheme 11. Triazole-substituted 3-hydroxypiperidine derivatives
87
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4.4.2. Internal Alkynes 
One advantage of RuAAC compared to CuAAC is that the former allows the use of internal 
alkynes, while the latter reaction involves the formation of a copper acetylide
53
 and thus requires 
a terminal alkyne. In the original report of the RuAAC reaction, Fokin and Jia included one 
example of a symmetrical internal alkyne with benzyl azide, showing that while the ruthenium-
catalyzed reaction afforded a 1,4,5-substituted triazole in 80% yield after 2 hours of reflux in 
benzene, the corresponding uncatalyzed reaction showed only trace amounts of product even 
after 24 hours (Scheme 12).  
Scheme 12.  First report of an internal alkyne in RuAAC
12
 
 
Inspired by this study, Majireck and Weinreb decided to apply unsymmetrical internal alkynes 
in RuAAC to investigate the regiochemical outcome when different substitution patterns on the 
alkyne were used.
77
 Standard reaction conditions were applied, involving the use of benzyl azide 
as the azide component and Cp*RuCl(PPh3)2 as the catalyst in refluxing benzene for 2 hours, 
using an excess of the alkyne relative to the azide. Isomeric ratios were measured by 
1
H NMR on 
the crude products and the regiochemistry of each isolated product was then verified by 
1
H NMR 
NOE. A selection of internal alkynes were also prepared by Fokin and Jia using Cp*RuCl(COD) 
as the catalyst in toluene at room temperature.
27
 Similar trends were seen by both groups (Fig. 7), 
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allowing some insight into factors that might govern the regioselectivity. Mixed alkyl/aryl-
substitued alkynes gave mixtures of regioisomers 17 and 18, and the same result was seen for 
alkynes bearing two different alkyl groups. However, an exception to this was seen for the 
reaction of benzyl azide with  4,4-dimethylpent-2-yne, bearing a methyl group on one of the 
acetylenic carbons and a tert-butyl group on the other, where triazole 19 was obtained with 
complete regioselectivity, albeit in a rather low yield. Triple bonds with an electron withdrawing 
group afforded triazoles with this group in the 4-position with complete selectivity (20 and 21). 
An alcohol or amine in the propargylic position of the alkyne instead resulted in the selective 
formation of triazole isomers where these substituents are in the 5-position of the triazole 
(compounds 22 and 23), explained by hydrogen bonding of –OH or –NH to the chloride ligand 
of the ruthenium complex.
27
 However, a homopropargylic alkyne was found to be unselective,
77
 
producing a mixture of the regioisomers, indicating that the hydrogen bond donor needs to be 
placed in the propargylic position and not further away. Poor regioselectivity when using 
homopropargylic alcohols has also been noted by Pelly.
88
 Majireck and Weinreb also found that 
alkynes containing heteroatoms connected directly to the triple bond also favoured the isomer 
where this heteroatom substituent ends up in the 5-position in the product, as seen in triazole 24. 
The regiochemistry can thus be summarized as follows: propargylic hydrogen bond donors, 
bulky substituents and heteroatoms will be found on C5 in the triazole, while electron deficient 
groups will be directed to C4. 
Figure 7. Regiochemistry in reactions of internal alkynes. Conditions: 
a 
Cp*RuCl(PPh3)2 (10 
mol%), benzene, 80 °C, 2.5 - 40 h;77 b Cp*RuCl(COD) (2 mol%), toluene, rt, 30 min.27 
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A more specialized class of internal alkynes was studied by Qing and colleagues,
89
 who 
focused their work on propargylic alcohols with a trifluoromethyl group connected to the alkyne. 
The precursor alkynes were made by treating 2-bromo-3,3,3-trifluoropropene with LDA 
followed by the addition of a ketone or aldehyde, to provide four different trifluoromethylated 
propargylic alcohols to evaluate in RuAAC, using either benzyl azide or n-octyl azide, and 
[Cp*RuCl2]n as the catalyst. Complete selectivity for isomers such as 25 (Scheme 13), with the 
CF3-group in the 4-position, was obtained, and the authors propose a polarity effect to explain 
the regiochemical outcome. A limited study was also performed using other reaction conditions, 
i.e. a thermal cyclization (80 ºC) performed in water and a Pd-catalyzed reaction carried out in 
refluxing benzene. Mixtures of regiosisomers were obtained in both these cases, demonstrating 
the utility of RuAAC in this context.  
Scheme 13. A trifluoromethylated propargylic alcohol in RuAAC
89
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C3-Symmetric tripodal triazole-containing ligands for copper(I) complexation have been 
described by Toth and colleagues.
90
 Propargylic alcohol 26 (Scheme 14) was reacted with benzyl 
azide in the presence of Cp*RuCl(COD), forming a 3:1 mixture of the two possible triazole 
regioisomers of 27. Following separation by chromatography, the major isomer was 
subsequently coupled via esterification to a central cyclohexane scaffold, affording tripodal 
ligand 28 which was found to be an efficient ligand for the CuAAC reaction. 
Scheme 14. A C3-Symmetric tripodal triazole ligand for Cu complexation
90
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Halogenated internal alkynes can be employed to form 5-halo-1,2,3-triazoles, and will be 
discussed in the next section.
91
 An internal bis-bithiophenyl alkyne has also been applied in 
RuAAC with good results.
92
 
4.4.3. Heteroatom-Substituted Alkynes  
Heteroatom-substituted alkynes have been applied in RuAAC, although there are few 
examples as yet in the literature. One of the early reports come from Cintrat and colleagues,
93
 
who applied three different ynamides (29-31) in RuAAC, providing access to 5-amido-1,2,3-
triazoles (Scheme 15). The authors had earlier reported the corresponding CuAAC reaction
94
 and 
now set out to develop methodology providing access to the other triazole isomer. An initial 
study using benzyl azide and N-benzyl-N-tosyl ynamide (29) with Cp*Ru(PPh3)2Cl as the 
catalyst at room temperature in toluene afforded solely the 1,5-disubstituted triazole isomer, and 
encouraged by these results, the authors screened a wide variety of functionalized azides in 
reactions with ynamides 29-31. Complete regioselectivity and good to excellent yields were 
obtained in all cases, although certain sterically demanding substrates needed longer reaction 
times and heating to drive the reaction to completion. One example of an internal alkyne was 
also included, affording selectively the isomer with the amido substituent in the 5-position of the 
triazole, following the same trend as for the terminal alkynes. 
Scheme 15.  Ynamides as alkyne substrates in RuAAC
93
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Another example of the use of nitrogen-substituted alkynes comes from Taddei and colleagues, 
in this case involving N-Boc-protected ynamides with a methyl ester functionality at the other 
end of the alkyne.
95
 The purpose was to prepare suitable building blocks for incorporating into 
triazole peptidomimetics, and these applications are covered in more detail in chapter 5.1. The 
authors wished to position the necessary carboxyl and amino functionalities closer to the triazole 
ring than is normally the case, and thus employed an alkyne where these two groups, in protected 
form, are directly appended to the triple bond. N-Boc-ynamides 32 and 33 were prepared in two 
steps from TIPS-protected bromoacetylene and subsequently converted to a wide range of 
functionalized N-Boc-5-aminotriazoles in high yields, employing [Cp*RuCl]4 as the catalyst 
(Scheme 16). An ynamide-derived 1,5-disubstituted triazole has also been reported by Diaz.
96
 
Scheme 16. RuAAC involving methyl N-Boc-aminopropiolates
95
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Halogenated internal alkynes have been investigated by Fokin and co-workers, affording 5-
halo-1,2,3-triazoles that can be further derivatized using palladium-catalyzed cross-coupling 
reactions.
91
 Cp*RuCl(COD) is commonly employed for room temperature RuAAC reactions,
27
 
but was found to be inefficient for reactions involving halogen-substituted internal alkynes. 
However, replacing Cp* with the less bulky Cp-ligand was found to solve this problem. A 
variety of alkyl azides reacted with bromo-, chloro- and iodo-substitued internal alkynes 
(Scheme 17). Aryl azides were inefficient in the reaction, but apart from this limitation, the 
reaction was found to tolerate a wide scope of substituents, including even a second heteroatom 
on the alkyne in the form of a phosphonate as in 34. Acetonitrile was found to be the most 
versatile solvent, and many of the reactions could be performed at room temperature, while a few 
more functionalized or sterically hindered substrates required heating to 50 ºC. Highest yields 
were in general obtained for chloro-substituted alkynes. The authors also showed that triazoles 
such as 35 could be employed in palladium-catalyzed transformations such as Sonogashira, 
Stille, Heck and Suzuki coupling (Scheme 18). Likewise, alkyne precursors substituted with a 
Weinreb amide as in 36 afforded triazoles that could be converted into aldehydes or ketones 
(Scheme 19). This possibility for further elaboration of the primary products into more complex 
structures makes this a very versatile methodology indeed. The halogenated alkynes were also 
employed in conjunction with nitrile oxides to form halooxazoles, as well as in 
cyclotrimerization reactions affording tri-brominated aromatics. 
Scheme 17.  RuAAC reactions of 1-haloalkynes
91
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Scheme 18.  Halogenated triazoles in Pd-catalyzed cross-coupling reactions
91
 
 
Scheme 19.  Synthesis of aldehydes and ketones from a triazolyl-functionalized Weinreb 
amide.
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Sulfur-substituted aryl alkynes were employed by Chen and Guo to prepare 
(trifluoromethyl)thio-substituted triazoles, potentially useful substrates for medicinal chemistry 
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purposes.
97
 Using 10 mol% Cp*RuCl(COD) in benzene, the reaction could be performed at room 
temperature, and three 1,4,5-trisubstituted triazoles were prepared in 68-85% yields (Fig. 8). 
HMBC (Heteronuclear Multiple-Bond Correlation spectroscopy), which can detect heteronuclear 
coupling over several bonds,
81
 was employed to confirm the location of the –SCF3 group at the 
5-position of the triazole. Reactions involving 2,2,2-trifluoroethyl-substituted alkynes also 
afforded the desired triazoles in high yields with the same regioselectivity. 
Figure 8.  (Trifluoromethyl)thio-substituted triazoles prepared via RuAAC
97
 
 
 
4.5. Ruthenium Catalysts 
The most commonly applied catalysts for RuAAC are Cp*RuCl(PPh3)2 and Cp*RuCl(COD), and 
a number of examples of their use have already been shown in earlier parts of this review. Table 
1 provides a summary of catalysts for RuAAC, together with selected references to their 
application, while the remainder of this section deals with more specialized Ru-catalysts as well 
as Ru-catalysts that afford the 1,4-disubstitued 1,2,3-triazole isomer. 
Table 1. Catalysts for the synthesis of 1,5-disubstiuted 1,2,3-triazoles via the RuAAC reaction 
with examples of reaction conditions
a
 
catalyst mol% cat solvent temp ref 
Cp*RuCl(PPh3)2 1-10 benzene 60-80 °C 
12,77,83,179,195,200, 211,218, 224 
 1-5 dioxane 40-100 °C (incl. w) 
12,132-133,207,219,221-222,248,251-
252,260,262 
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 1-28 THF 25-100 °C (incl. w)  
27,71,87,132,177-178,180,192,204-206,212-
213,217,220,223,225,229,231,253-
256,258,264,268,271-272 
 1-20 toluene 25-120 °C 93-94,96,125,132,156,171,191,193-
194,204,226-227 
 2-5 DMF 70-120 °C (incl. w) 
111,142,202,209 
 2 MeCN 90 °C (incl. w) 
219 
 10 DCE 80 °C 237 
 10 CH2Cl2 50 °C 
228 
Cp*RuCl(COD) 5-10 benzene 25-80 °C 12,97,197 
 1-5 DCE 45 °C 52,196 
 2-20 toluene 25-110 °C 27,88,120,122,129,132,191,227 
 4-25 THF 25-66 °C 104,132,215-216,223,250,267,272 
 2-4 dioxane 25-100 °C 120,132,169,190,208 
 20 DMF 60 °C (incl. w) 
112,270 
 6 DMA 100 °C (w) 
189 
CpRuCl(COD) 3-10 MeCN 25 °C 91 
 3-10 DMF 25 °C 91 
CpRuCl(PPh3)2 3-5 benzene 80 °C 
12,92 
 2 THF 75 °C 27 
 6 DMA 100 °C (w) 
65 
Cp*RuCl(NDB) 5 benzene 80 °C 12 
 2 THF 75 °C 27 
[Cp*RuCl]4 2-50 THF 25-120 °C 
27,234,236,244-245 
 30 THF/MeOH 50 °C 160-161 
 2.5-10 DMF 25-115 °C (incl. w) 
52,95,169,188,214,230,244-245,249,257 
 5-15 toluene 40-110 °C 156,227,157,168 
[Cp*RuCl2]n 4-10 THF 40-100 °C (incl. w) 
69,271,119,149 
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a
 For RuAAC reactions on solid phase, see Table 2. 
4.5.1. Ruthenium Catalysts Affording the 1,5-Disubstituted 1,2,3-Triazole 
Catalysts employed for the RuAAC reaction are generally 18-electron complexes such as the 
above mentioned Cp*RuCl(PPh3)2 and Cp*RuCl(COD). Nolan and co-workers investigated the 
effect of using 16-electron ruthenium complexes of the general structure Cp*RuLX in RuAAC, 
where L was a phosphine or carbene ligand, and X either chloride or alkoxide.
63
 The mechanistic 
aspects of this study have already been described in detail in chapter 3 and will be only briefly 
mentioned here. Using the reaction between phenyl acetylene and benzyl azide as a test system, 
seven different ruthenium complexes were evaluated as catalysts for the cycloaddition at room 
temperature in dichloromethane, with a reaction time of 40 minutes. Best results were obtained 
when L was a phosphine and X a chloride ligand (Fig. 9, 37 and 38). Replacing chloride with –
OCH2CF3 was detrimental to the reaction, and complex 39 afforded only 2% product. Among 
complexes with carbene ligands, use of the bulky IAd (40), with adamantyl substitutents on the 
carbene, was the most successful, albeit affording a lower yield than for the phosphine-
substituted complexes. 
Figure 9. 16-electron ruthenium complexes evaluated in RuAAC. 
 
Lo and colleagues prepared several ruthenium-azido complexes bearing Tp 
(trispyrazolylborate) ligands and found that complex 41 (Fig. 10), was an efficient catalyst for 
the RuAAC reaction between benzyl azide and various terminal acetylenes.
98,99 
Interestingly, the 
catalyst gave similar results in toluene and in water. 
 39 
Figure 10. Ruthenium azido complex 41 with Tp ligands for RuAAC reactions in water. 
 
A practical approach to RuAAC was reported by Astruc and co-workers, who prepared 
ruthenium complex 42 (Fig. 11) for immobilization onto magnetic nanoparticles, allowing for 
facile recycling of the catalyst.
100
 A triarylphosphine linker with a pendant trimethoxysilyl group 
was employed to tether the pentamethylcyclopentadienyl ruthenium(II) catalyst to the surface of 
a silica-coated -Fe2O3 nanoparticle. The catalyst was highly selective for the 1,5-disubstituted 
1,2,3-triazole isomer and afforded good yields for a range of alkynes and azides, including also 
an internal alkyne. Facile catalyst recovery was effected using a magnetic field, and the catalyst 
could be recycled up to five times without substantial loss in selectivity and yield. 
Figure 11. A ruthenium catalyst for immobilization on an iron-oxide based magnetic 
nanoparticle.
100
 
 
4.5.2. Ruthenium Catalysts Affording the 1,4-Disubstituted 1,2,3-Triazole 
In the original reports by Jia and Fokin, it was noted that ruthenium catalysts lacking a 
cyclopentadienyl ligand afforded the 1,4-disubstituted isomer instead of the 1,5-disubstituted 
1,2,3-triazole.
12,27
 Although such compounds can be accessed via CuAAC, it was nevertheless of 
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interest to evaluate the range of ruthenium-catalysts that were applicable in this variant of the 
cycloaddition as well as to investigate the scope of substrates that could be used. Liu and Jia 
focused on the most active of the earlier studied catalysts, i.e. RuH2(CO)(PPh3)3.
101
 Using 5 
mol% catalyst in THF at 80 °C, a wide variety of different 1,4-disubstituted triazole products 
could be produced. Of interest is the synthesis of podophyllotoxin derivative 43 (Scheme 20); 
derivatization of this natural product RuAAC has also been reported by Tron (see section 5.5) 
but in this case the triazole replaced the lactone functionality. A one-pot cycloaddition/transfer 
hydrogenation, using the same catalyst for both reactions, was also described. Liu has also 
shown that the ruthenium-catalyzed cycloaddition can be performed in water using the same 
catalyst, with a lower catalyst loading (0.2%) than when using an organic solvent.
102
 A 
convenient one-pot method for directly accessing the 1,4-disubsituted triazoles via in situ 
formation of the azide from the corresponding bromide was also included in this study (Scheme 
21).  
Scheme 20.  Formation of 1,4-disubstituted 1,2,3-triazoles using RuH2(CO)(PPh3)3
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Scheme 21.  One-pot cycloaddition reaction on water directly from an alkyl bromide
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In a later paper by Jia, together with Liu and Fokin, a larger range of ruthenium catalysts was 
instead explored.
62
 Two new catalysts in particular, i.e. RuH(2-BH4)(CO)(PCy3)2 and 
Ru(C≡CPh)2(CO)(PCy3)2, were found to give both high yields and a fast reaction. A wide range 
of alkynes and three different azides were explored in RuAAC using catalyst RuH(2-
BH4)(CO)(PCy3)2. Although tert-butylacetylene as well as an aryl azide were difficult substrates, 
all other azide/alkyne combinations afforded triazoles in high yields (71-95% yield). Mechanistic 
studies, involving also DFT calculations, indicate a ruthenium acetylide as a key intermediate. 
Porphyrin derivatization is an example of where Ru-catalysts that form the 1,4-disubstituted 
isomer can be put to good use, as the Cu-catalyst used for CuAAC can result in copper inserting 
into the porphyrin. If this is not desired, blocking the central coordination site with Zn(II) is 
necessary, but this involves extra reaction steps.
103
 As part of a study on porphyrin-vitamin B12 
conjugates, Gryko and co-workers employed RuH2(CO)(PPh3)3 to append triazoles onto a central 
porphyrin scaffold functionalized with an azide (44, Scheme 22) or an alkyne.
104
 However, 
although the desired 1,4-disubstituted structures were obtained, this catalyst afforded low yields 
and substantial amounts of byproduct formation. This strategy was thus abandoned and the 
authors instead returned to CuAAC, finding after some optimization that [Cu(phen)(PPh3)2]NO3 
could provide the 1,4-isomers without copper insertion. A set of 1,5-isomers were also 
successfully prepared as part of this study, again with precursor 44 but this time using 
Cp*RuCl(COD) as the catalyst (Scheme 22). As a point of interest, Gallo explored ruthenium 
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porphyrin complexes as catalysts for RuAAC but found that reaction of an aryl azide with an aryl 
alkyne produced indoles rather than the expected triazoles.
105
 
Scheme 22.  Ruthenium-catalyzed derivatization of porphyrins
104
 
 
Lee employed ruthenium nanoparticles in ruthenium-catalyzed 1,3-cycloadditions reaction, 
where the catalyst was prepared by calcination of ruthenium hydroxide at 500 °C under a 
hydrogen atmosphere.
106
 The 1,4-triazole isomers were obtained in this case, and of particular 
interest is the formation of tris-triazoles 45 and 46 in 60% and 64% yield, respectively, using this 
catalyst system (Fig. 12). The ruthenium nanoparticles could be recycled three times without any 
significant change in morphology or catalytic activity. 
Figure 12. Tris-triazoles formed via cycloadditions involving Ru(0) nanoparticles.
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Another example of a supported catalyst has been described by Tuhina and Islam,
107
 in this 
case employing a polymeric support in contrast to the nanoparticles employed by Astruc (section 
4.5.1)
100
 and Lee.
106
 The polymer-bound ruthenium(III) catalyst 47 (Scheme 23) was prepared by 
reaction of RuCl3 with a polystyrene-tethered -alanine ligand, affording a supported catalyst 
containing 8.5 weight% ruthenium (determined by AAS). To test the catalyst in RuAAC, phenyl 
acetylene was mixed with sodium azide and benzyl bromide in the presence of varying amounts 
of the supported catalyst. By evaluation of the reaction conditions, including exploration of a 
wide range of organic solvents, the authors concluded that water provided the best medium for 
this transformation. Employing 2 mol% catalyst and a reaction time of 3 hours at 40 ºC produced 
the 1,4-disubstitued 1,2,3-triazole in quantitative yield, after a simple workup involving only 
filtration, washing with ethanol and concentration. The substitution pattern of the product is not 
surprising considering that the catalyst contains neither a Cp nor a Cp* ligand, and this result is 
thus in accord with earlier studies by Jia and Fokin.
12,27
 The scope of the reaction was further 
investigated by introducing substituents on the aromatic groups of the precursors, with product 
yields in the range of 83-94% (see Scheme 23 for an example). The recyclability was 
investigated and the supported catalyst could be employed up to six times without noticeable 
reduction in catalytic activity. The polymer-bound catalyst was also investigated in transfer 
hydrogenation of aromatic and aliphatic ketones with good results. 
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Scheme 23. Polystyrene-supported Ru(III) complex 47 in one-pot RuAAC in water
107
 
 
4.5.3. Ruthenium Catalysts Affording Other Substitution Patterns 
An interesting ruthenium-catalyzed tandem reaction has been described by Bhattacharjee and 
co-workers.
108
 In the presence of silver, the ruthenium compound [Ru(dppp)2(CH3CN)Cl][BPh4], 
prepared from either RuCl2(PPh3)3 or RuCl3·nH2O, could effect the homocoupling of alkynes via 
the formation of silver acetylenides. After heating the reaction for 30 minutes, sodium azide was 
added and after an additional 6-8 hours, a product was formed where one of the two triple bonds 
had participated in a cycloaddition reaction to form a 4,5-disubstituted 1,2,3-triazole (Scheme 
24). Five different substrates were isolated in good yields. Attempts to replace NaN3 with an 
alkyl azide did not afford any triazole product. 
Scheme 24. A tandem ruthenium-catalyzed homocoupling/cycloaddition reaction in the presence 
of a silver salt
108
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4.6. Solid Phase RuAAC Reactions 
The use of solid phase synthesis (SPS) can sometimes be advantageous, especially in solid phase 
peptide synthesis (SPPS). The RuAAC reaction has been successfully applied using SPS 
methodology by several groups,
109-113
 where SPS RuAAC works under similar conditions as the 
solution phase reaction in terms of catalysts, temperature, and solvent. An increased amount of 
catalyst and slightly prolonged reaction time seems, as expected, to be beneficial due to the 
slower reaction kinetics on solid phase. Furthermore, a variety of different resins have been 
employed with good results. The various reaction conditions employed for SPS RuAAC are 
summarized in Table 2.  
Table 2. Summary of conditions reported for the RuAAC reaction on solid phase 
resin catalyst % cat solvent temp time ref 
chlorotrityl resin Cp*RuCl(COD) 20% toluene 45 °C 16 h 109 
Amphispheres resin
a
 Cp*RuCl(COD) 20% DMF 60 °Cb 5 h 110 
Wang resin Cp*RuCl(PPh3)2 5 % DMF 70 °C 22 h 
111 
TentaGel S AC resin Cp*RuCl(COD) 20 % DMF 60 °C 5 h 112 
Rink Amide Cp*RuCl(PPh3)2 NA THF 70 °C 8 h 
113 
a 
Amphispheres 40 HMP resin. 
b
 Microwave heating. 
 
5. MEDICINAL AND BIOLOGICAL APPLICATIONS 
Since catalysts suitable for RuAAC became commercially available, numerous applications in 
the field of medicinal chemistry, biochemistry and drug discovery have been reported. This 
chapter aims to give an overview of different strategies that have been applied in the various 
fields, with the properties of 1,5-triazoles in mind. 
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5.1. Peptidomimetics 
Compounds that mimic peptides in terms of their secondary structure and/or biological functions, 
but which can exhibit other beneficial properties such as improved proteolytic stability or 
improved affinity to a desired target, are known as peptidomimetics.
114
 A broad range of 
different peptidomimetics have been developed, and their use has become a standard tool in 
medicinal chemistry and drug research today.
115
 The field can be broadly divided into three 
categories, involving scaffold-based peptidomimetics as well as local and global modifications of 
the parent peptide. The aim of peptidomimetic design is to either maintain or improve biological 
activity, increase selectivity and most importantly, increase proteolytic stability. In this chapter 
we will discuss the properties and applications of the RuAAC reaction as a tool for 
peptidomimetic applications. 
5.1.1. cis-Amide-Bond Mimetics 
In natural peptides and proteins, most of the amide bonds in the peptide backbone are populated 
in their low energy trans-conformation, which is used in the construction of α-helices and β-
sheets. However, the ability to form a high energy cis-conformation, especially for cis-prolyl 
peptide bonds (~6% of all Xaa-Pro peptide bonds in nature), may influence the secondary 
structure, as well as many processes such as the rate of protein folding.
116
 In proteins, the cis-
conformation can be stabilized by additional intramolecular hydrogen bonds and/or disulfide 
bonds, which is normally not the case for small peptides. The ability to mimic cis-amide bonds 
governs the possibility to study such biological systems and provides an opportunity for drug 
design and research. The 1,5-disubstituted 1,2,3-triazole exhibits similar properties to a cis-
amide bond, particularly concerning the distance between the two adjacent α-carbons (3.2 Å in 
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the 1,5-triazole versus 3.0 Å in a cis-amide bond) (Fig. 13) and thus constitutes a good mimic for 
a cis-amide bond, despite lacking hydrogen bond donor abilities. 
Figure 13. 1,2,3-Triazoles as trans- and cis-amide bond mimics.
14,117
 
 
Appella and co-workers were among the first to demonstrate the synthesis of a 1,5-
disubstituted 1,2,3-triazole amino acid (48, Scheme 25) for use as a cis-amide bond mimic, albeit 
not using RuAAC, in order to induce turn formation in an unnatural peptide in aqueous 
solution.
118
 1,5-Triazole amino acid 48 was synthesized via a non-catalyzed thermal Huisgen 
cycloaddition in a five-step route with an overall yield of 31%. The synthesis of such derivatives 
has later been improved using the RuAAC reaction, affording the corresponding triazole amino 
acid protected with Boc instead of Fmoc, in 75% yield over two steps.
119
 Insertion of triazole 48 
into an unnatural peptide sequence using solid phase peptide synthesis (SPPS) leads to peptoid 
49, (Scheme 25), which adapts a hairpin-like turn structure as the major conformer in 10 mM 
sodium phosphate buffer (pH 7.0), as revealed by detailed NMR experiments. 
Scheme 25. Synthesis of amino acid 48 and insertion into peptoid 49
118
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The synthesis and use of 1,5-disubstituted 1,2,3-triazoles as cis-prolyl peptide bond mimics has 
been studied by Raines and co-workers,
120
 who found that the Xaa-1,5-triazole-Ala unit mimics 
an Xaa-cis-Pro dipeptide remarkably well. By using the RuAAC reaction, a number of protected 
Xaa-1,5-triazole-Ala building blocks such as 50 and 51 were prepared in moderate to high yield 
(Scheme 26). 
Scheme 26. Synthesis of Xaa-1,5-triazole-Ala building blocks via the RuAAC reaction
120
 
 
Bovine pancreatic ribonuclease A (Rnase A), consisting of 124 residues, was used as a model 
protein to test the concept of 1,5-triazoles as cis-peptide bond mimic. The region Gly112-
Asn113-Pro114-Tyr115 in the protein sequence forms a Type VIb reverse turn where Asn113-
Pro114 has a cis-peptide bond. This dipeptide segment can be mimicked rather well by Xaa-1,5-
 49 
triazole-Ala. Triazoles 50 and 51 were incorporated in a peptide sequence corresponding to 
residues 95 to 124 by using standard solid phase peptide synthesis. No epimerization was 
observed during the basic Fmoc-deprotection steps of the peptide synthesis. Residue 1 to 94 was 
created by recombinant DNA methods. After ligation of the two sequence parts, the protein was 
folded, purified, and the enzymatic activity was compared with the native ones. The two 1,5-
triazole-containing enzymes obtained showed catalytic activities comparable to the wild type 
analogs. It can be concluded that the Xaa-1,5-triazole-Ala building blocks are efficient mimics of 
the cis-peptide bond conformation in Xaa-Pro residues, as the catalytic activities are closely 
related to the formed protein tertiary structure.
121
 
A similar cis-prolyl bond mimetic has also been described by Tietze and applied as a LeuPro 
cis-peptide bond mimetic in the synthesis of a mimic of the nickel superoxide dismutase 
(NiSOD) metallopeptide.
122
 The Fmoc-protected 1,5-triazole amino acid 52 was synthesized 
using 4% Cp*RuCl(COD) as the catalyst, followed by deprotection of the tert-butyl ester, and 
was then inserted into heptapeptide 53 using standard SPPS. (Scheme 27) Metallopeptide 54 was 
obtained by treating triazole peptide 53 with one equivalent of aqueous NiCl2 solution and 
titration to pH 7.8. 
Scheme 27. Synthesis of 1,5-triazole amino acid 52 and metallopeptide 54
122
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Ferrini et al. have prepared a slightly different 1,5-triazole as a peptide backbone mimetic that 
exhibits the ability to mimic β-turns.95 As discussed in section 4.4.3., the 5-aminotriazole was 
obtained exclusively when using N-Boc-aminopropiolates in the RuAAC reaction. These 5-
aminotriazoles are appealing as peptide backbone mimetics, as they are equipped with three 
functional groups that can be used for peptide synthesis or functionalization. Conformational 
analysis by computational methods (MM, QM and MD) revealed that triazole 55 (Fig. 14) has 
some populated conformers satisfying reverse turn requirements, and one of the two most stable 
conformers shows the CO-HN hydrogen-bond typical for β-turns.  
Figure 14. A backbone peptidomimetic based on a 5-aminotriazole structure
95
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Tischler et al. have also employed a 1,5-triazole as a cis-peptide mimic.
112
 They targeted the 
Ile-cis-Pro amide bond in the highly potent sunflower trypsin inhibitor 1 (SFTI-1).
123
 In the 
native form, its 14 amino acid backbone GRCTKSIPPICFPD is cystine bridged and head-to-tail 
cyclized, and the Ile-cis-Pro amide bond is fundamental for bioactivity. By applying RuAAC in 
standard Fmoc SPPS (see chapter 4.6), 1,5-triazole cis-peptide bond mimics could be prepared 
and the disulfide bridge was obtained by DMSO or air mediated oxidation on the crude peptide. 
The trypsin inhibition activity of the mimics was tested, and the most potent compound, with a 
Ki of 34 nM, was found to be the triazole-containing 56 (Fig. 15). 
Figure 15. A mimic of the Ile-cis-Pro amide bond.
112
  
 
5.1.2. Peptide Side-Chain Mimetics 
In addition to mimetics of the peptide bond and peptide backbone, there are also side-chain 
mimetics, where the role of such mimetics can be to stabilize interactions or activated species 
made by the side-chain in the native peptide. Peptide side-chain mimetics are also frequently 
used to constrain peptide conformations and to stabilize secondary structures such as helices, 
commonly termed stapled peptides.
124
 In this chapter the use of 1,5-triazoles as side-chain 
mimetics will be discussed. 
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Roux et al. have utilized CuAAC and RuAAC reaction to synthesize orthogonally protected 
1,2,3-triazoles as histidine mimetics.
125
 Starting from propargyl glycine, various 1,4-protected 
triazoles and a limited number of 1,5-triazoles were prepared. One could question the motivation 
for making the protected 1,5-triazoles, as the 1H-1,2,3-triazol-4-yl is favored over the 1H-1,2,3-
triazol-5-yl by 2.0 kcal/mol and will be in an equilibrium shifted towards the 1,4-regioisomer 
after deprotection irrespective of the route used.
126
 Nevertheless, Fmoc and pivaloyloxymethyl 
(POM) protected
127
 1,4-azaHis mimics were utilized in SPPS of Gly-His-Lys (GHK) analogue 
57 (Scheme 28). GHK is an endogenous tripeptide known as a growth-modulating factor, a 
strong activator of wound healing, with copper chelating properties.
128
 However, no biological 
evaluation of compound 57 was reported. 
Scheme 28. Synthesis of 1,5-triazole-containing Gly-His-Lys analog 57
125
 
 
Interesting stable phosphohistidine (pHis) mimetics and phosphoryltriazolylalanines (pTza) 
have been developed by Kee et al.
129
 A cycloaddition of diethyl ethynylphosphonate with 
protected azidoalanine under both CuAAC and RuAAC conditions gave the desired pTza 
derivatives 58 and 59 in 72% and 68% yield, respectively (Scheme 29). According to molecular 
modeling, these compounds display favorable pHis-mimetic properties in terms of geometry and 
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electronics. Particularly the hydrolytic liability of the original phosphohistidine moiety is 
overcome by the replacement of the labile N-P bond with a stable C-P bond.  
Scheme 29. Synthesis of stable pHis mimetics
129
 
 
With the two stable pHis isomers pTza 58 and 59 at hand, the possibility to study the function of 
pHis in biological systems was opened. It is known that histone H4 histidine kinase (HHK) 
activity is up-regulated by 200-fold in human hepatocellular carcinomas compared to normal 
liver tissue.
130
 Stabile pHis analogs could thus be useful tools, enabling the study of histone 
histidine phosphorylation. Peptides 60 and 61 (Scheme 30) were designed and synthesized by 
SPPS. These compounds correspond to the N-terminal tail of human histone H4 protein (residues 
14-23), containing either the 1-pHis or the 3-pHis analog instead of His18.
131
 
Scheme 30. Solid phase synthesis of histone H4 tail peptides containing stable 3-pHis and 1-
pHis mimics
129
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Triggered by the possibility that the pTza peptides 60 and 61 could be used in the generation of 
antibodies that can selectively recognize pHis in phosphoproteins, peptide 60 was employed as 
an immunogen to obtain rabbit polyclonal antibodies such as Ab-3pHis. Ab-3pHis is an example 
of an antibody that selectively recognizes a pHis-containing protein. Accordingly, Ab-3pHis was 
formed and its specificity was determined by peptide dot blot assays with a series of histone H4 
tail peptides, harboring the two pTza isomers (60, 61) as well as the His, pTyr, pSer, and pThr 
analogs. As Ab-3pHis only recognizes 60 and not 61 or the other phosphorylated analogs, no 
cross-reactivity towards His or other phosphoamino acids was demonstrated. Western blot 
analysis showed that Ab-3pHis selectively recognizes the histidine-phosphorylated histone H4, 
but not the nonphosphorylated counterpart.  
Buysse et al. have investigated amino triazolo diazepines (Ata, Fig. 16) as constrained histidine 
mimics and demonstrated their potential as histidine mimics by replacement of the His-Pro 
dipeptide in angiotensin IV and subsequent evaluation in two enzyme inhibition assays.
132
 
Figure 16. Histidine (left) and amino triazolo diazepine (Ata) (right).
132
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Two different strategies for the synthesis of such Ata-Xaa dipetidomimetics were explored as 
seen in Scheme 31. Route A, involving the initial amide coupling of Boc-β-azido-Ala 62 with N-
propargyl amino acid methyl ester 63 followed by a thermal Huisgen cycloaddition to form 64, 
was found to be unsatisfactory, not only due to low yields but also to a considerable degree of 
epimerization. Route B, employing an intermolecular RuAAC reaction followed by 
intramolecular lactamization, proved superior both in terms of yield and suppressed 
epimerization after optimization of the reaction conditions. The Ata-Gly dipeptidomimetic 64 
was applied to the angiotensin IV sequence, Val-Tyr-Ile-His-Pro-Phe, using standard SPPS. The 
activity of this modified sequence was determined by measuring the inhibition of insulin-
regulated aminopeptidase (IRAP) and aminopeptidase-N (AP-N). Inhibition activitity of the 
peptidomimetic was in principle the same as measured for the original peptide (pKi IRAP = 7.09 
vs. 7.14), concluding that Ata functions as a potent mimic for His. 
Scheme 31. Comparison of thermal versus RuAAC synthesis of Ata-Xaa dipetidomimetics 64
132
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Keller and Pyne have reported the synthesis of mono-, di- and tripeptidomimetics, introducing 
a C-terminal triazole as an ester isostere, using both CuAAC and RuAAC.
133
 The antibacterial 
activity of the compounds was evaluated, with a particular focus on the gastric anaerobe 
Clostridium difficile, where two dipeptides with a 1,5- and 1,4,5-substitution pattern were among 
the most active.  
5.1.3. -Helix Mimetics 
Among the tremendous number of biological processes that occur in all living cells, a large 
portion of these involve protein-protein interactions (PPIs). The ability to control and modulate 
PPIs is of great significance for increased understanding of these processes, as well as for the 
development of new molecular therapeutics. The discovery of cell-permeable small-molecular 
inhibitors of PPIs is still a big challenge, partly due to the absence of natural small-molecular 
ligands, the inherent conformational flexibility of proteins, and also because of the lack of simple 
suitable binding assays. Helical secondary structure motifs are the most abundant forms in 
proteins and correspond to over 30% of the structures. For that reason, it is rational to imagine 
that a significant population of PPIs should involve α-helices, and that a mimic of a helix 
recognition face could act as a small-molecular competitive inhibitor.
134-137
  
α-Helix mimetics can be divided into three different categories. Type I mimetics are short 
oligomers that strive to replicate the local topography of an α-helix. These often involve peptide 
backbone mimetics with the aim to stabilize the helical conformation and to improve proteolytic 
stability; examples are stapled peptides and foldamers (foldamers are discussed in section 5.1.4). 
Type II mimetics are small non-peptidic molecules that bind to a peptide receptor but do not 
necessarily mimic the original helix structure and rather serve as functional mimetics.
134
 Type III 
mimetics are non-peptidic scaffolds that mimic the surface formed by non-sequential hot-spot 
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residues of the α-helix.138-140 Attempts to use 1,5-triazoles in such Type III α-helix mimetics have 
recently been reported by König111,141 as well as by Grøtli.142 Both groups have designed and 
synthesized mimics bearing three side-chains, which by calculated lowest energy conformation 
mimic the orientation of the side-chains in an α-helix at position i, i+3 and i+7. The König group 
used Cp*RuCl(PPh3)2 as catalyst in dioxane at 70 °C to obtain the bistriazole scaffold 65 in good 
yield (Fig. 15). Grøtli and colleagues synthesized the 8-(1,5-triazolyl)-purine scaffold 66 under 
microwave conditions at 120 °C in DMF, (Fig. 17) aiming at fluoroscent PPI inhibitors of the 
MDM2/p53 interaction. Disappointingly, however, these compounds showed no activity in the 
fluorescence polarisation (FP) assay. Thus, a biologically active 1,5-triazole-based α-helix 
mimetic still remains to be discovered. 
Figure 17. Attempted α-helix mimetics111,141-142  
 
 Foldamers 
In the area of peptidomimetics, non-natural peptidic oligomers having the capacity to mimic 
structural and folding properties of natural peptides are called as “peptidic foldamers” or 
“foldamers”. The field was originally initiated by two parallel papers published by Seebach et 
al.
143
 and Gelmann et al. in 1996.
144
 By now, foldamers demonstrate diverse secondary structures 
and also very exotic side chain chemistry for the non-natural amino acid-like building units.
145-146
 
Peptidic foldamers are useful tools in target validation and can also provide additional modalities 
when designing drugs for challenging target classes like PPIs.
147
 As already mentioned above, 
since helical and turn structures are easily achieved by employing backbones involving cyclic 
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insertions,
145-146
 both the 1,4- and the 1,5-substituted 1,2,3-triazole ring coupled with N- and C-
terminal groups of amino acids have accordingly come up as novel “triazole amino acids” with 
an application potential as non-natural insertions into natural amino acid sequences.
14,148
 The 
important abilities, such as stability against degrading enzymes, or more controlled secondary 
structures, also hold for the 1,5-disubstituted 1,2,3-triazole amino acids insertions, which 
promotes their potential use as creating foldamer oligomers. By applying 4 mol% [Cp*RuCl2]n in 
the RuAAC reaction, Johansson et al.
119
 obtained the 1,5-disubstituted 1,2,3-triazole amino acid 
67 in excellent yield (Scheme 32). Accordingly, these amino acids were also oligomerized into 
triazole foldamers, resulting in short δ-peptide trimer and tetramer (68) derivatives showing 
diverse structural properties and having several conformations present simultaneously in solution 
phase.
119
 The relatively rich set of stable conformers for the 1,5-disubstituted triazole amino 
acids, the on-purpose extended nature of their 1,4-regioisomers,
149
 and their applicability in both 
standard peptide synthesis and expressed protein ligation,
120
 has already provided some initial 
studies toward the “foldamer direction”.119,150-151 The latter examples together also foreshadow a 
rapid increase in the number of new promising triazole foldamer constructs in the near future. 
Scheme 32. Synthesis of 1,5-triazole amino acid 67 and tetramer 68
119
 
 
 
5.2. Macrocycles 
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In the last decade, the interest for macrocycles as drug leads has grown,
152-153
 especially in the 
case of non-peptidic macrocycles, due to their generally more favorable properties, i.e. higher 
metabolic stability and permeability, which facilitate their use as oral drug candidates. 
Macrocycles populate a different chemical space than the space traditionally seen as druggable 
according to Lipinski’s rule of five.154 The turn-like structure of 1,5-disubstituted 1,2,3-triazoles 
makes them excellent motifs for incorporation into macrocycles.
155
 Two different strategies can 
be employed for the introduction of a 1,5-disubstituted triazole in a macrocycle. Either the 
triazole formation can be used in the macrocyclization step or the 1,5-triazole moiety can be 
introduced prior to the cyclization step. Both strategies have been utilized by several groups and 
will be discussed in this chapter. 
Horne et al. have employed the 1,5-triazole as a cis-peptide bond mimetic in a conformational 
study of apicidin, a naturally occurring cyclic tetrapeptide inhibitor of histone deacetylases 
(HDACs).
109
 They initally tried to apply the triazole formation as the macrocyclization step in 
order to access both the 1,4- and 1,5-triazoles (69 and 70) via the same linear intermediate 71, as 
shown in Scheme 33. A 2:1 mixture of 1,5- and 1,4-triazole was obtained when using thermal 
Huisgen cycloaddition conditions, but the 1,5-triazole 70 was isolated in only 8% yield.  When 
RuAAC was instead applied to introduce the 1,5-triazole in the middle of the sequence, using 
solid phase methodology, subsequent macrolactamization in solution after cleavage from the 
resin afforded the macrocycles 72-74 in 9-10% total yield (based on resin loading) over 8 steps 
and with >95% yield in the macrocyclization step (Scheme 34). The macrocyclization in this 
case is greatly favored by the turn conformation of the linear precursor 75 containing the 1,5-
triazole which brings the ends closer together. 
Scheme 33. Microwave-assisted thermal Huisgen macrocyclization
109
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Scheme 34. Synthesis of macrocycles 72-74 utilizing the RuAAC reaction
109
 
 
Reaction conditions: 
a 
Fmoc- L-Leu-CCH or Fmoc- D-Leu-CCH, Cp*RuCl(COD) (20 mol %), 
toluene, 45 °C, 16 h; b HATU, DIPEA, 0.5 mM in DMF, 1.5 h, > 95% yield.  
Extensive NMR studies of the macrocycles revealed one single conformation in solution for 
69,72 and 73, but 70 and 74 indicated a population of multiple conformations. The solution 
conformation of macrocycle 69 corresponded well with all-trans conformations of the peptide 
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backbone in apicidin, while 73 overlapped closely with the less present c-t-t-t conformation and 
74 formed the c-t-c-t conformation. The NMR study, together with enzyme activity data, 
suggests that the less populated (15%) c-t-t-t conformation of apicidin is the more bioactive one. 
The first report of a successful method for using the RuAAC as the macrocyclization step was 
published by the Marcaurelle group.
156
 They desired a method that could produce non-peptidic 
macrocycles, of ring size both n and n+1, from a single starting material by using different 
catalysts. After some optimization they found that [RuClCp*]4 was more advantageous 
compared to the classic Cp*RuCl(PPh3)2 in terms of monomer/dimer ratio. Dimer formation is 
usually the most common issue in all macrocyclizations in solution. Dilution and increased 
temperature was also beneficial for the monomer/dimer ratio. The RuAAC conditions were 
optimized on azido-alkyne 76, and with the optimized conditions in hand, a number of 11-,12- 
and 13-membered macrocycles were synthesized in good yields. Some selected examples are 
shown in Scheme 35.  
Scheme 35. Synthesis of triazole macrocycles using RuAAC as the macrocyclization step
156
  
 
The same group then utilized this method in a large diversity-oriented synthesis (DOS) library in 
their search for new macrocyclic histone deacetylase inhibitors (HDACs),
157
 using a three phase 
DOS strategy called build/couple/pair (B/C/P), a method described in more detail in section 
5.7.
158
 In the pair phase, different macrocyclic structures of a linear intermediate were subjected 
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to different reactions, including RuAAC, to generate a total of 48 macrocyclic scaffolds ranging 
from 8- to 14-membered ring systems. These 48 scaffolds were then finally further diversified on 
solid-phase by utilizing SynPhase Lantern technology
159
 to produce a library of more than 
30 000 compounds. The RuAAC macrocyclization reactions were reliable and were routinely 
performed on 5-10 g scale in 50-80% yield. An example is shown in Scheme 36. 
Scheme 36. Macrocyclization by RuAAC affording 12-membered triazole macrocycles
157
 
 
Zhang et al. studied two different strategies for making triazole macrocycles in their synthesis 
of macrocyclic vancomycin mimics.
160-161
 Macrocyclization by RuAAC was successful but with 
some difficulty for the smallest ring 77 (n=1), due to rigidity of the corresponding linear azido-
alkyne 78 (n=1), giving rise to both dimer and trimer by-products (Scheme 37). However, when 
the 1,5-triazole was introduced in the linear sequence using 79, and the ring closed via 
lactamization instead, the yield of the macrocyclization step was enhanced from 14% to 47% for 
the smallest ring size. The amount of dimer formation was equal, 28% vs. 31%, for the two 
methods, but the trimer by-product was not formed during the macrolactamization.  
Scheme 37. Comparison of RuAAC-macrocyclization and macrolactamization
160
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The same group also utilized a RuAAC double-macrocyclization in the synthesis of a 1,5-triazole 
bridged vancomycin bicyclic mimic.
161
 By treating the linear bis azido-alkyne 80 with 
[Cp*RuCl]4 in THF/MeOH for 24 hours at 50 °C, the bicyclic bis-triazole macrocycle 81 in was 
obtained in 40% yield, which can be considered high for this level of complexity (Scheme 38),  
Scheme 38. Double RuAAC-macrocyclization
161
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Disulfide bridges are very common and important in oligopeptides and proteins as they 
contribute to defining tertiary folding and conformational stability of proteins. One special group 
of naturally occurring peptides are called cysteine knot miniproteins
162
 or cyclotides.
163-166
 These 
are cyclic peptides with three crosslinked disulfide bridges. The disulfide bridges provide the 
cyclotide with extraordinary thermal stability and resistance against protolytic degradation.
167
 
The in-vitro generation of disulfides bridges is usually achieved post-synthetically and is not 
always straightforward, especially for controlled regiospecific formation of such linkages. 
Empting et al. have demonstrated successful mimicking of the disulfide bridge by introducing 
a 1,5-triazole into an analog of the sunflower trypsin inhibitor-I (SFTI-1) 82 (Scheme 39).
110
 
Macrocyclization of the linear azido-alkyne 83, using RuAAC on solid phase, yielded the 
triazole macrocycle 84 after deprotection and cleavage from the resin. Overlay of energy-
minimized models of 84 with a previous solution structure of 82 (PDB code:1JBN)
123
 showed a 
comparable distance (4.00 vs. 4.18 Å) between the two Cα atoms of residue 3 and 11. The 
inhibition of trypsin-catalyzed proteolysis was also tested and interestingly no significant drop in 
activity was seen. This methodology could be useful in the future in controlling folding of 
peptides where several disulfide formations are possible.   
Scheme 39. Solid phase RuAAC synthesis of macrocycle 84 and structure of the sunflower 
trypsin inhibitor-I 82
110
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Isodro-Llobet et al. have also utilized the RuAAC reaction as a macrocyclization strategy in a 
diversity oriented synthesis of macrocyclic peptidomimetics,
168
 applying the three phase DOS 
build/couple/pair strategy mentioned earlier.
158
 In the pair phase, the RuAAC macrocyclization 
method developed by the Marcaurelle group
156-157
 was employed to cyclize linear compounds 
85-87 to obtain triazole macrocycles 88-90 in good yields and without any epimerization 
(Scheme 40). The triazole macrocycles were then further diversified by diketopiperazine (DKP) 
formation using solid supported N-methylmorpholine, acetic acid, and microwave heating. 
Scheme 40. Synthesis of 21-membered triazole macrocycles by RuAAC macrocyclization
168
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Krause et al. utilized RuAAC for both macrocyclization and for preparation of the linear 
precursor 91 in their synthesis of the C3-symmetrical tris-1,5-triazole macrocycle 92 (Scheme 
41).
169-170
 They studied the anion-binding properties of triazole macrocycle 92 by extensive 
NMR and ITC (isothermal titration calorimetry) experiments and found that 92 binds Cl, Br, I 
and sulfate in both protic and aprotic solvents in a 1:1 ratio with high affinity. The synthesis of 
92 (Scheme 41) involves three RuAAC reactions and starts with the cycloaddition of freshly 
prepared azide 93 to alkyne 94 to form the 1,5-triazole 95 in good yield. Worth mentioning is 
that azide 93 dimerizes under neat or concentrated solutions upon standing at room temperature 
and it is thus crucial to use newly prepared azide 93 in order to obtain a good yield. The second 
RuAAC reaction afforded the linear intermediate 91, but required a longer reaction time and 
benefitted from the addition of triphenylphosphine to keep the catalyst active. Compound 91 was 
then, after deprotection and azide introduction, macrocyclized to tris-triazole macrocycle 92 
using [Cp*RuCl]4 and microwave heating in dilute ~2 mM DMF solution.    
Scheme 41. Synthesis of an anion binding tris-triazole macrocycle via three sequential 
RuAAC reactions
169
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Fang et al. used RuAAC for macrocyclization to obtain 11- and 12-membered macrocycles,
171
 
using previously reported unoptimized conditions
156
 but with a slightly higher temperature 
(Scheme 42). Macrocycles 96 and 97 were obtained in moderate to good yield, but it remains 
uncertain to what degree the yield was reduced by any dimer formation.  
Scheme 42. RuAAC macrocyclization forming 11- and 12-membered triazole derivatives
171
 
 
To conclude this chapter of 1,5-triazole containing macrocycles, one can easily realize the 
utility of the 1,5-triazole as a building unit due to its natural turn conformation. As discussed in 
the beginning of this chapter, the two strategies to either introduce the 1,5-triazole prior or during 
macrocyclization are both fruitful, as shown by the many examples discussed. The optimal 
strategy depends heavily on the nature of the linear precursor for a given macrocycle. In general, 
introduction of the 1,5-triazole prior to the macrocyclization increases the yield of the 
macrocyclization step due to its conformational preorganization. However, the use of RuAAC as 
macrocyclization reaction can also be effective, but it is very much dependent on the flexibility 
of the linear precursor and also the size of the ring to be formed. 
 
5.3. Nucleoside and Nucleotide Analogues 
Nucleosides and nucleotides both contain a nucleobase (also called nitrogenous base) connected 
to a ribose or deoxyribose unit and in the case of nucleotides also linked to one or more 
phosphate groups (Fig. 18), providing many potential sites for derivatization. Synthetic 
 68 
compounds of this type are of interest for instance in the development of antivirals and 
anticancer agents.
172-174
 A triazole unit can be employed to either derivatize or entirely replace 
the nucleobase moiety, or it may be appended to the base or to the sugar unit, to afford a 
nucleoside analogue. Subsequent phosphorylation also provides access to nucleotides. As for 
many other areas of drug discovery, reported applications of triazole incorporation mainly 
employ CuAAC,
175
 while RuAAC has been less investigated in this context. 
Figure 18. Nucleosides and nucleotides with many potential sites for derivatization. 
 
5.3.1. Replacing or Derivatizing the Nucleobase via RuAAC 
Ribavirin (Scheme 43) is an antiviral agent, mainly used in the treatment of hepatitis, but also to 
combat the respiratory syncytial virus (RSV).
176
 Agrofoglio and co-workers prepared a set of 
ribavirin-like compounds by replacing the 1,3-disubstituted 1,2,4-triazole ring in ribavirin with a 
1,4- or 1,5-disubstituted 1,2,3-triazole.
71
 A benzoyl-protected -azido-ribose was subjected to 
RuAAC conditions using Cp*RuCl(PPh3)2 as the catalyst in THF (Scheme 43). Microwave 
heating was found to be more efficient than thermal heating in this case and the desired 
derivatives were obtained in good to excellent yields using a reaction time of only 5 minutes. 
Minor amounts of the 1,4-disubstituted isomer accompanied the formation of the desired 1,5-
isomer, but this byproduct could be removed by chromatography. Unprotected azido-ribose 
could also be applied in the reaction with excellent results. The prepared compounds were not 
found to display any activity towards the hepatitis C virus (HCV) upon screening, however.
176
 
Scheme 43. Ribarivirin analogues with the nucleobase replaced by a triazole
71
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The same group prepared nucleoside derivatives with a triazole appended to the C5 position of a 
2’-deoxyuridine structure using the microwave conditions for RuAAC described above.177 
Compounds 98-101 were obtained in good yields (Scheme 44) and could be deacetylated using 
ammonia in methanol. While the corresponding 1,4-disubstituted derivatives, prepared using 
CuAAC, displayed some antiviral and cytostatic activity, the 1,5-isomers were inactive. Similar 
triazoles were also reported by Nielsen for use in DNA-RNA duplexes.
178
 
Scheme 44. Triazole derivatives of 2’-deoxyuridine177 
 
5.3.2 Derivatization of the Ribose or Deoxyribose Unit via RuAAC 
The attachment of a triazole to the sugar moiety instead of the nucleobase in the nucleoside 
structure has been reported by several groups, and the prepared structures are summarized in Fig. 
19.
27,93,179-182
 
Figure 19.  Derivatization of the nucleoside ribose or deoxyribose via RuAAC. 
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The most extensive study in this area has been reported by Wang, with the purpose of 
investigating the antiviral properties of nucleoside analogues.
180-182
 3’-Azidothymidine (AZT, 
Fig. 18) was one of the earliest drugs employed towards the Human Immunodeficiency Virus 
(HIV),
183
 but treatment with this drug can be accompanied by undesired side effects. As the AZT 
structure contains an azido functionality already at the outset, a natural strategy for derivatization 
would be the formation of triazoles via CuAAC or RuAAC. Previous attempts to investigate this 
pathway towards analogues did in general not afford compounds with antiviral activity, but the 
explored triazole side chains were in most cases aliphatic. However, aryl-substituted triazole-
AZT derivatives were reported to show potent thymidine kinase 2 (TK-2) inhibition.
184
 Inspired 
by this, Wang and colleagues prepared a number of both 1,4- and 1,5-disubstituted triazole-AZT 
derivatives containing aromatic substituents (see Fig. 18 for two RuAAC derivatives).
180
 
Standard conditions (Cp*RuCl(PPh3)2, THF, 60 °C) were employed for the RuAAC reaction but 
extended reaction times (1-2 days) were required to obtain the products in sufficient amounts. 
These compounds were then screened towards HIV-1, employing a cytopathic effect (CPE) 
based assay. Many of the prepared compounds displayed antiviral activity. Especially 1,5-
 71 
substituted triazole compounds with bulky substituents, such as the 1-naphthyl derivative 102, 
(Fig 20) showed promising properties. Triphosphates of selected compounds were also prepared. 
Interestingly, silylation of the free hydroxyl group in derivatives such as 102 and 103 with tert-
butyldimethylsilyl chloride afforded compounds displaying antiviral activity towards the 
Western Nile and Dengue viruses.
182
 
Figure 20. Triazole analogues of AZT.
180
 
 
Having successfully derivatized the 3’-azidothymidine structure, Wang and colleagues then 
turned to the corresponding 4’-azidothymidine (ADRT, Scheme 45), but here ran into 
problems.
181
 While ADRT could be converted into various compounds using CuAAC, albeit 
involving long reaction times and heating to 60 °C, the corresponding RuAAC reaction did not 
proceed at all despite extensive efforts to vary the reaction conditions. The azide in ADRT is 
tertiary as compared to the secondary azide in 3’-azidothymidine (Fig. 18), and steric hindrance 
is believed to be the cause of this low reactivity. 
Scheme 45. RuAAC inhibited by steric hindrance
181
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Etheve-Quelquejeu and co-workers focused on the cycloaddition of 3’-azidoadenosine with 
chiral alkynes to form analogues of aminoacyl-tRNA.
179
 Benzoyl-protected 3’-azidoadenosine 
104 (Scheme 46) was reacted with two different chiral propargylic amine derivatives to form 
triazoles 105 and 106 in 37 and 39% yields, respectively, using standard conditions for the 
RuAAC reaction. Compound 105 was then coupled with commercially available deoxycytidine 
phosphoramidite to form dinucleotide 107 after deprotection. Ligation of 107 to an RNA micro-
helix completed the synthesis to form the desired aminoacyl-tRNA analogue. 
Scheme 46. Synthesis aminoacyl-tRNA analogues using RuAAC
179
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5.4.  Glycomimetics 
Carbohydrates are important structural starting motifs in drug design as they are involved in 
inter- and intracellular communication in many organisms.
185
 Moreover, carbohydrate analogues 
and mimetics are commonly exploited as transition state analogues for enzyme inhibition, and as 
tools for understanding enzyme inhibition mechanisms.
186
 The use of CuAAC in carbohydrate 
chemistry has been recently reviewed.
187
 The RuAAC reaction has been used as a method to 
couple carbohydrate moieties to each other as well as to connect saccharides to aromatics or 
other functionalized units, forming new carbohydrate derivatives. Several of the resulting 
compounds possess properties that make them promising as future therapeutic lead structures. 
The first application utilizing the RuAAC reaction in a carbohydrate context was reported by 
Cintrat and co-workers,
93
 as part of their investigation of ynamides as the alkyne component in 
the cycloadditions (see section 4.4.3). Included among the azide substrates was acetylated -D-
galactopyranosyl azide 108 (Scheme 47), which reacted with ynamide 29 (Scheme 15) under 
ruthenium catalysis, to afford the 1,5-substituted triazole 109 in good yield. 
Scheme 47. Reaction of an ynamide with a glycosyl azide
93
 
 
The RuAAC reaction can also be used to couple two carbohydrate units to each other. The 
Crich group was the first to exploit the triazole motif as a linker in this manner, to provide a 
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compound resembling a trisaccharide.
188
 [Cp*RuCl]4 was employed as the catalyst in DMF 
under microwave irradiation at 110 °C to afford an azidomethyl glycoconjugate linked by a 1,5-
disubstituted triazole in 75% yield (Scheme 48). The corresponding 1,4-substituted isomer was 
also synthesized using CuAAC. 
Scheme 48. Connecting carbohydrates via a triazole linker using RuAAC
188
 
 
A similar strategy has been applied by Opatz and co-workers, who in their search for 
metabolically stable glycomimetics demonstrated that pivaloylated and acetylated 
galactosylazides can be coupled with fucosylacetylene selectively, forming the corresponding 
1,5-diglycosylated 1,2,3-triazoles (Scheme 49).
189
 Cp*RuCl(COD) was employed as the catalyst 
under microwave irradiation at 100 °C in DMA. Yields were 76% for the acetylated and 60% for 
the pivaloylated galactosylazides, respectively. The corresponding 1,4-isomers were obtained 
using the CuAAC reaction. 
Scheme 49. Coupling of a galactosylazide with a fucosylacetylene
189
 
 
Multivalent glycoclusters can be synthesized employing the RuAAC reaction as a key step. 
Uhrig and Kovensky have proved that a variety of multivalent thiogalactosides and thiolactosides 
can be formed using various azidosugars and carbohydrate-containing alkyne linkers.
190
 With the 
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aid of Cp*RuCl(COD) as the catalyst at room temperature in dioxane, a number of different 
glycoclusters, such as tetravalent compound 110 and even up to octavalent derivatives, were 
synthesized and evaluated as ligands for peanut lectin (Scheme 50). The yields varied depending 
on the substrate, stretching from 35% up to 82%. 
Scheme 50. Formation of tetravalent glycocluster 110
190
 
 
Furthermore, Supuran and Poulsen have demonstrated the formation of 1-(β-D-glycosyl)-5-
benzenesulfonamide-1,2,3-triazole compounds with carbonic anhydrase inhibitory properties.
191
 
Acetylated sugar azides such as compound 111 were allowed to react with p-
ethynylbenzenesulfonamide using Cp*RuCl(COD) as the catalyst (Scheme 51). Five different 
triazoles were prepared, and alkaline hydrolysis of the acetal groups afforded the deprotected 
structures. 
Scheme 51.  Reaction of a sugar azide 111 with p-ethynylbenzenesulfonamide
191
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The azide can be located in alternate positions of the saccharide ring. Besra and co-workers 
prepared triazole derivatives from 6’’-azido-6’’-deoxy-alpha-galactosyl ceramide (112) and 
phenyl acetylenes in 72-78% yield, employing 5 mol%  Cp*RuCl(PPh3)2 as the catalyst (Scheme 
52).
192
 Both a terminal and a disubstituted internal alkyne were employed, with slightly lower 
yields for the product from the internal alkyne substrate. 
Scheme 52. Synthesis of triazole-containing -galactosyl ceramides192 
 
2,3,6-Trideoxysugar triazole hybrids are yet another class of carbohydrate-like compounds that 
have been examined as potential drugs, more specifically as new broad spectrum antimicrobial 
agents. The Shaw group synthesized a library of sugar-1,4-triazole conjugates for this purpose.
193
 
and included one example of a 1,5-triazole (Fig. 21), using Cp*RuCl(PPh3)2 as the catalyst. The 
same group also synthesized a class of bicyclic iminosugar hybrids exploiting an intramolecular 
version of the RuAAC reaction as the key reaction step.
194
 Both thermal and ruthenium-catalyzed 
conditions were examined, where the bicyclic triazole product 113 was produced in both higher 
yield and shorter reaction time using the Ru-catalyzed reaction (Scheme 53). 
Figure 21. Synthesis of a sugar-1,4-triazole conjugate
193
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Scheme 53. Intramolecular RuAAC reaction yielding bicyclic iminosugar hybrids 
194
 
 
 
5.5. Natural Product Analogues 
Various natural products have been employed as core structures for triazole-containing 
analogues, generally with the purpose of evaluating the biological properties of these new target 
compounds for comparison with the original molecule. Several groups have studied potentially 
cytotoxic derivatives, based on lignin,
195
 alkaloid
196
 and natural phenolic
197-198
 scaffolds. Tron 
and co-workers envisaged that the same two building blocks, i.e. piperonyl alcohol and 3,4,5-
trimethoxybenzylalcohol, could be employed to prepare triazole derivatives of the cytotoxic 
lignans steganacin and podophyllotoxin.
195
 RuAAC involving 114 and 115, using 
Cp*RuCl(PPh3)2 as the catalyst, afforded a precursor that could be oxidatively coupled to form 
derivative 116 (Fig. 22). The same strategy using 117 and 118 instead provided analogue 119 in 
a good overall yield. This methodology was not directly applicable towards the podophyllotoxin 
analogues, however. A modified reaction sequence involving a Friedel-Crafts reaction to effect 
the final ring closure allowed the formation of 120, albeit in a rather low yield, and the remaining 
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compound 121 could not be prepared using either of these strategies. Compounds 116, 119 and 
120 were all found to display some degree of cytotoxic activity upon screening.  
Figure 22. Triazole analogues of steganacin and podophyllotoxin.
195
  
 
Ferrocene-substituted chalcones have been connected to cinchona alkaloids using both CuAAC 
and RuAAC as reported by Csámpai and co-workers.196 The ruthenium-catalyzed cyclization of 
122 and 123, using Cp*RuCl(COD) as the catalyst, was accompanied by Ru-catalyzed 
epimerization at the C9 position, affording 124 in 48% yield, together with a byproduct where 
the azide had been reduced to an amino group (Scheme 54). Both 124 as well as the 
corresponding 1,4-isomer displayed an improved in vivo cytostatic activity towards HepC2 
hepatoma and HT-29 colorectal adenocarcinoma human tumor cell lines in comparison to the 
reference compound Tamoxifen, with the 1,5-isomer 124 being the more active of the two. 
Scheme 54. Cytostatic ferrocene-triazole-cinchona alkaloid hybrids
196
 
 79 
 
Combrestatin A-4 is a cytotoxic natural product isolated from the bark of the tree Combretum 
caffrum, found in South Africa.
199
 Hansen and co-workers had earlier prepared analogues of 
combrestatin, where the cis double bond, necessary for activity, had been replaced by a triazole 
ring in order to lock the two aromatic rings into a cis relationship. Both 1,4- and 1,5-disubstituted 
triazoles were included in this previous study,
197
 but the 1,5-compounds were prepared using 
magnesium acetylides. In a more recent study, seeking to investigate the effect of introducing a 
methylene group between the triazole nitrogen and the trimethoxy-substituted aromatic ring, 
compounds 125 and 126 were prepared in excellent yields using Cp*RuCl(COD) in refluxing 
benzene (Scheme 55).
198
 Although the 1,5-disubstituted triazole derivatives were found to be 
more cytotoxic than their 1,4-counterparts, the introduction of the extra methylene carbon was 
not found to be beneficial for the biological activity. 
Scheme 55. Triazole derivatives of combrestatin A-4
198
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Appendino and Di Marzo employed vanillin as a core unit in the preparation of synthetic 
capsaicinoids, where the amide unit of capsaicin (Scheme 56) was replaced by a triazole moiety 
to improve stability towards hydrolysis.
200
 Vanillin was converted into protected vanillazides 
127, and subsequently reacted with 1-decyne under Cu(I) or Ru(II) catalysis. While the copper-
catalyzed conversion proceeded with excellent regioselectivity for the 1,4-isomer in both cases, 
the corresponding ruthenium-catalyzed reaction somewhat surprisingly afforded mixtures of the 
1,4- and 1,5-disubstitued isomers of 128 and 129. The isomers could be separated by preparative 
HPLC, however, and the activity of the prepared compounds towards vanilloid and cannabinoid 
receptors was compared to that of capsaicin itself as well as other synthetic derivatives. 
Scheme 56. Derivatives of capsaicin and olvanil
200
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The fatty acid side chain of capsaicinoids may contain double bonds and the presence of at 
least one such olefin unit in these compounds is believed to be important both for passive 
transport across cell membranes as well as for interaction with the vanilloid receptor. Triazoles 
can act as mimics for the geometrical constraints imposed by double bonds (see chapter 5.1.1.) 
and to investigate this feature, triazole analogues of olvanil, where the double bond was replaced 
by a triazole, were prepared via CuAAC and RuAAC (Scheme 56, only RuAAC reaction 
shown), and their vanilloid activity was evaluated. Both the 1,4- and the 1,5-isomer were found 
to be less active than olvanil itself. However, the 1,5-isomer 130 (Scheme 56), which more 
closely mimics the cis isomer of olvanil, was found to be more active than the corresponding 1,4-
isomer, and this is in line with the activity of the two double bond isomers of olvanil, where the 
cis isomer is more active than the trans isomer.  
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Analogues of naamine A, a natural product isolated from calcareous sponges, were prepared 
by Blache and co-workers, with the purpose of evaluating the ability of these compounds to 
control the formation of bacterial biofilms.
201
 A set of compounds with variation of both the 
substitution pattern of the aromatic rings as well as the chain length between the triazole and the 
substituents were prepared from the corresponding azides and alkynes via RuAAC, using 
Cp*RuCl(PPh3)2 as the catalyst. Compound 131 (Fig. 23) showed the most interesting anti-
biofilm activity, while the hydroxylated analoges were found to be inactive. 
Figure 23.  Analogues of naamine A for evaluation of their biofilm inhibitory activity.
201
  
 
1,5-Disubstituted triazole derivatives of the triterpenoid oleanoilic acid have been prepared by 
Jannet and co-workers using Cp*RuCl(PPh3)2 as the catalyst under microwave conditions.
202
 The 
anticancer and anti-inflammatory properties of the compounds were evaluated, and one of the 
prepared 1,5-isomers was found to show anticancer activity against murine breast and human 
colon cancer cells. 
 
5.6. Target-Oriented Medicinal Chemistry 
Over the last 10 years, the utilization of the RuAAC reaction in drug discovery has been noted 
as a growing trend in the literature. A diverse set of 1,5-triazole products can be found in these 
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reports which cover a wide range of targets and target classes including various enzyme 
inhibitors,
203-213
 kinases,
214-217
 proteases,
110,112
 antivirals
218
 (see also chapter 5.3) G-protein 
coupled receptors (GPCRs),
219
 ion channels,
220-222
 heat shock proteins,
95
 and tRNA ligands.
223
 
1,5-Triazole derivatives have shown activity against numerous cancer cell lines,
205,215,224-227
 and 
against the parasites Trypanosoma cruzi
70,228
 and Plasmodium falciparum.
205
 They have also 
been employed in the search for new antimicrobiotics
229
 and antifungal agents.
230
 Some selected 
examples are shown in Fig. 24 to demonstrate the broad diversity of 1,5-triazoles in target 
oriented medicinal chemistry. Many of these 1,5-triazoles have been made without any rational 
design behind, but rather to obtain structural diversity or by scaffold hopping. However, some 
examples have been made with more design in mind, as exemplified by Miyakoshi et al. who 
applied 1,5-triazole 132 as a mimic of a locked cis-conformation of an amide bond in an early 
deoxyuridine-triphosphatase (dUTPase) inhibitor hit (Fig. 24).
208
 Further optimization lead to a 
potent dUTPase inhibitor. Interestingly, in vivo experiments of this triazole together with 5-
fluorouracil (5-FU), showed significantly enhancement of the antitumor activity of 5-FU against 
a breast cancer model (MX-1 xenograft) in mice. Yang et al. investigated 1,5-triazoles as 
replacements for the bioactive cis-amide bond of the HCV NS5B polymerase inhibitor 133 (Fig. 
25).
211
 Overlay of the relevant lower energy conformation of triazole 134 with an X-ray for the 
bound structure of 133 displayed potential for a good replacement, although a 3-4 fold drop in 
inhibition against HCV NS5B was seen. Linking different binders together into conjugates with 
dual or polypharmacological properties is another emerging area of interest for the 
pharmaceutical industry, especially in targeting strategies for drug delivery. Two exciting 
examples using RuAAC as a linkage strategy have been reported. In the first example by 
Chardon et al.,
225,231
 some inspiring results were obtained when the RuAAC reaction was 
 84 
employed to link an ER ligand with a cytotoxic Pt
II
-complex for potential targeting of hormone-
dependant diseases (e. g. breast, colon and ovarian cancers). A 1,5-triazole (135, Fig. 24) was 
obtained in 41% yield using 8 mol% Cp*RuCl(PPh3)2 in THF at 70 °C overnight. A CuAAC 
reaction of similar precursors failed to deliver the 1,4-triazole product, most likely since 
dihalocomplexes of palladium (and platinum) are known to react with terminal alkynes in the 
presence of a copper(I) catalyst and amine base as a method for preparing acetylide complexes 
with Sonogashira-type reactivity.
232-233
 A 1,5-triazole displayed in vitro cytotoxic activity against 
several cancer cell lines, however its selectivity towards positive oestrogen receptor cancer cells 
has not yet been evaluated in vivo. The second example of a 1,5-triazole linked dual inhibitor is 
triazole 136 reported by Ko et al (Fig. 26).
215
 In this case, the selective c-Src kinase kinase (a key 
signaling kinase in cancer) inhibitor 137, reported by Brandvold et al.,
216
 was combined with the 
histone deacetylase (HDAC) inhibitor 138 to afford the chimeric Src/HDAC inhibitor 136, which 
is the first in class dual c-Src/HDAC inhibitor. Interestingly both the c-Src and HDAC binding 
affinities of 136 increased compared to each corresponding smaller inhibitor. Chimera 136 also 
showed similar or better growth inhibition of several cancer cell lines in the National Cancer 
Institute’s panel screen (NCI-60 panel) compared to vorinostat and dasatinib.215 Wang has 
recently published the use of chloromethyl triazoles (CMTs) as a new warhead for covalent 
inhibitor.
226
 A range of CMTs were synthesized using RuAAC and their activity against O
6
-
alkylguanine DNA methyltransferase (MGMT) was determined, with 139 (Fig. 24) being 
identified as a potent and selective covalent inhibitor of MGMT. Labeling experiments of the 
C145A MGMT mutant and wild type (WT) protein with a probe CMT also showed that these 
compounds bind exclusively to the active site cysteine 145. 
Figure 24. Selected examples of RuAAC-derived inhibitors and ligands. 
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Figure 25. 1,5-Triazole as cis-amide bond mimic in HCV NS5B inhibitors
226
 
 
Figure 26. RuAAC-derived chimeric c-Src/HDAC inhibitor 136
215
 
 
 
5.7. Diversity-Oriented Medicinal Chemistry 
CuAAC and RuAAC provide convenient methods for elaborating a central molecular scaffold to 
increase chemical complexity, as use of either an azide or an alkyne as the point of 
derivatization, in combination with the possibility to vary the metal catalyst, can provide access 
to four different types of 1,2,3-triazole units appended onto the same scaffold.  
The build/couple/pair (B/C/P) strategy,
158
 already mentioned in section 5.2., involves the 
synthesis of molecular scaffolds (build phase), subsequent coupling of different combinations of 
these scaffolds using the same coupling reaction (couple phase), followed by the pair phase that 
instead employs different reactions that will define the final structures of the molecules prepared. 
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Spring and co-workers have taken this method one step further in the formation of DOS-derived 
macrocycles, by employing different reactions in the couple phase, thus allowing for a higher 
degree of diversification when combining two scaffolds.
234
 Macrocycles of a non-peptidic nature 
are often difficult to prepare and are thus not well represented in compound collections employed 
for pharmaceutical screening purposes. Azido building blocks, of different geometries and 
containing a fluorous tag to facilitate purification 
235
 were constructed and then coupled, not 
using cycloadditions, but via aza-Wittig-type reactions. The RuAAC and CuAAC reactions were 
instead reserved for the final macrocyclization step, constituting the pair phase. A total of 73 
macrocycles were prepared, and two examples, formed via RuAAC at high dilution in the final 
step, can be seen in Fig. 27. In a later paper,
236
 RuAAC was applied in an example of 
multidimensional DOS, where a functional group introduced during the build/couple/pair phases 
is reacted further, thus providing an additional possibility for diversification (i.e. 
build/couple/pair/modify).  
Figure 27.  Macrocycles formed via RuAAC using [Cp*RuCl]4 as the catalyst
234
 
 
Looking more at classical DOS methods involving RuAAC, Park has described the synthesis 
of a benzopyran library,
237
 also using solution-phase fluorous-tag chemistry. Described as 
privileged-substructure-based DOS (pDOS), the central benzopyran scaffold being considered a 
privileged structure in drug discovery,
238-239
 Park and colleagues prepared a set of 32 
benzopyranyl triazoles with a 1,5-substitution pattern in high yields and purities, using 
Cp*RuCl(PPh3)2 as the catalyst (see Fig. 28 for selected examples). Aryl azides were excluded 
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from the study, as initial experiments showed that these substrates were problematic in RuAAC, 
in line with earlier reports by Lin, Jia and Fokin
27
 (see chapters 2 and 4.1.).  
Figure 28. Selected compounds from a 60-membered library of benzopyranyl triazoles
237
 
 
Another report of the use of RuAAC for DOS purposes comes from the group of Zondlo,
113
 
who employed this reaction in the context of proline edition, i.e. modification of a proline 
residue within a peptide chain with the purpose of studying the steric and stereoelectronic effects 
of this variation on the peptide conformation. A total of 123 different peptides were prepared by 
functionalization of a 4-hydroxyproline moiety within a peptide attached to a solid support. 
Diversification was effected using a wide range of both organic and organometallic reactions and 
included the formation of two diastereomeric 1,5-disubstituted triazole following conversion of 
the 4-hydroxyl unit of prolinol to an azide. 
 
6. ORGANOCATALYSTS 
Chiral pyrrolidines are often employed as organocatalysts, their extensive application triggered 
by the original discovery by List and co-workers, showing that L-proline itself is an efficient 
catalyst for asymmetric aldol reactions.
240
 Luo and Cheng investigated the organocatalytic 
asymmetric Michael addition of ketones and aldehydes to nitroolefins.
241
 L-proline itself, while a 
viable catalyst, is known to afford low enantioselectivities in this reaction,
242
 there were 
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indications that substituted derivatives such as L-prolinol could be more successful. Seeking a 
convenient method for derivatizing a proline scaffold, the authors employed CuAAC produce a 
library of 1,4-disubstituted triazoles to be used as organocatalysts for screening purposes. Two 
1,5-disubstituted triazoles were also prepared (140 and 141, Scheme 57), but as this study was 
published only shortly after the initial report on the RuAAC reaction, the authors here employed 
the more classical magnesium acetylides (see chapter 2) to attain the 1,5-isomeric structure 
instead. Catalysts 140 and 141 both performed well in the reaction between cyclohexanone and 
2-nitrovinylbenzene (Scheme 57), but only marginal differences were seen between 140 and the 
corresponding 1,4-substituted isomer 142, indicating that the space-shielding effect of the 
triazole ring itself was more important than the positioning of the substituents. Thiazolidine-
based scaffolds were also explored but found to be inefficient as catalysts in the reaction. 
Scheme 57. Triazole-substituted pyrrolidines as organocatalysts in a Michael addition
241
 
 
Thioureas are also priviliged structures in organocatalysis, and the bifunctional organocatalyst 
143 (Fig. 27), containing this moiety, was originally designed by Takemoto for the 
enantioselective Michael addition of malonates to nitroolefins.
243
 The catalyst contains both 
acidic and basic units and was constructed on the principle that these two sites will activate one 
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reactant each, while simultaneously bringing them into close proximity to facilitate reaction. 
Seeking to expand this concept towards a trifunctional organocatalyst, Takemoto and Takasu 
constructed a set of triazole-substituted thioureas employing both RuAAC and CuAAC.
244
 
Although the RuAAC reaction is compatible with a wide spectrum of functionalities, the sulfur 
atom in a thiourea can ligate to the ruthenium catalyst, causing deactivation. A synthetic strategy 
where the thiourea unit was introduced in the last step was thus envisaged, and catalysts of the 
type 144 (Fig. 29) were prepared using a microwave-mediated RuAAC reaction with 
[Cp*RuCl]4 as the catalyst, followed by coupling reactions to introduce the thiourea in the final 
step. Screening of three of the catalysts in the enantioselective conjugate addition of 
cyclohexanone to trans--nitrostyrene afforded up to 92% ee. In a later study, the scope of aryl-
substituted nitroolefins was expanded, with a 2-furyl substituted nitroolefin affording up to 98% 
ee using these organocatalysts.
245
 
Figure 29. Synthesis of trifunctional organocatalysts for Michael additions to nitroolefins
244-245
  
 
 
7. SUPRAMOLECULAR STRUCTURES, NANOCHEMISTRY AND ELECTRONIC 
DEVICES 
Triazole formation provides a convenient method for elaborating supramolecular structures 
which often contain a complex central scaffold, and require a simple and high yielding reaction 
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for the final step. CuAAC has been extensively used for this purpose,
246-247
 while examples using 
RuAAC are more scarce. The aromatic properties of the triazole also make these units well 
suited for inclusion into molecules intended for electronic devices or nanochemistry applications, 
where an extended conjugated system is often desired.  
De Cola and colleagues have investigated the effect of introducing triazoles into iridium 
complexes bearing difluorophenyl-pyridine (F2ppy) ligands.
248
 Metal complexes can be 
employed in light-emitting diodes (LEDs), acting as phosphorescent dopants and facilitating 
intersystem crossing from the singlet to the triplet excited state. The colours red, green and blue 
are all necessary for applications in color displays, and De Cola found that a complex prepared 
via RuAAC, using Cp*Ru(PPh3)2Cl as the catalyst, displayed blue emission with high quantum 
yields (Fig. 30).  
Figure 30. A triazolyl iridium complex with blue-emitting properties
248
 
 
Theranostic agents combine both diagnostic and therapeutic properties into one entity, and 
seeking to develop contrast agents for optoacoustic imaging, Franchini employed both copper 
and ruthenium catalyzed cycloadditions to link silver nanoparticles (NPs), derivatized with an 
alkyne unit, to lipophilic azide-functionalized gold nanorods (GNRs).
249
 The cycloadducts were 
subsequently incorporated into PEG-based co-polymers to produce polymeric nanoparticles 
(PNPs). These new constructs were found to display similar electroacoustic and optical 
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behaviour to GNR-PNPs without silver NPs, indicating that click-attachment of silver NPs does 
not disturb the desired properties. 
Xie and co-workers employed both CuAAC and RuAAC to derivatize benzothiadiazoles 
(BTDs) intended for fluorescent chemosensors.
250
 Comparing structure 145 with its 1,4-
disubstituted counterpart (Scheme 58), the authors found significant differences in the spectral 
properties of the molecules, where blue shifts for 145 relative to the corresponding 1,4-isomer in 
the absorption and emission spectra were attributed to a lesser degree of conjugation in 145, due 
to a larger dihedral angle between the triazoles and the central BTD unit. Binding studies to 
various metal ions were also carried out. Sensors for metal binding have also been reported by 
Quayle and colleagues, who employed both CuAAC and RuAAC for clicking together a reporter 
unit (azo dye) with a metal recognizing moiety (macrocycle) and a carrier molecule 
(carbohydrate).
251
  
Scheme 58. Triazole-derivatized benzothiadiazoles for fluorescent chemosensors
250
 
 
Ruthenium(II) polypyridyl complexes, where one or two pyridyl ligands were replaced by 1,5-
disubstituted triazoles, were synthesized by Schubert and co-workers,
252
 and alkylation of the 
triazoles with methyl iodide also gave access to ruthenium triazolylidene complexes. The 
electrochemical and photochemical properties of 146-148 (Fig. 31) were investigated and 
 93 
complemented by computational studies using DFT. These compounds emit red light and could 
be of interest in electroluminescence devices, although evaluation in a dye-sensitized solar cell 
gave modest efficiency in terms of power conversion. Red emissive triazole luminogens have 
also been prepared by Qin and Tang, using CuAAC and RuAAC to adorn a pyrazine structure.
253
 
The compounds were shown to have good luminescence properties in the aggregate and solid 
state, which can be of importance in the development of optoelectronic devices for instance. 
Figure 31. Triazole ruthenium complexes displaying red emission
252
 
 
Tetrathiafulvalenes (TTFs) are frequently employed for the construction of molecular materials 
due to their electroactive properties. In a series of reports, Avarvari has investigated the 
structures and properties of a TTF-scaffold functionalized with 1,5-disubstitued triazole units.
254-
256
 Employing a tetrathiafulvalene with one or two appended alkyne units, compounds 149-154 
(Fig. 32) were prepared via RuAAC, using Cp*RuCl(PPh3)2 as the catalyst in THF at 65 °C.
254
 
Cyclic voltammetry and DFT calculations showed 149 and 150 to be more electron deficient and 
less prone to oxidation than their 1,4-disubstitued counterparts. Cu(II)-complexes of these 
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ligands were prepared and characterized by X-ray crystallography, where the triazole N3 atom 
was found to bind to copper. These metal complexes are predicted to be useful starting materials 
for paramagnetic molecular conductors. In a second study, the solid state structure of 149 and 
analogue 153 was compared. Interestingly, despite their similarities, these compounds crystallize 
in a different fashion, where 150 forms head-to-tail dimers while 153 is arranged in columns 
with each unit slightly shifted in comparison to the molecule above and below so that the TTF-
moiety stacks with a triazole unit directly above.  The effect of protonation and alkylation of the 
triazole ring in 149 was also studied,
256
 and a triazolium salt was formed via treatment of with 
trimethyloxonium tetrafluoroborate ((Me3O)BF4). A third report focused on chelating pyridine-
triazole structures, i.e. 152 and 154, and their ability to act as ligands for metals such as cobalt 
and cadmium.
255
 
Figure 32. Triazole-containing tetrathiafulvalenes (TTFs)
254-256
 
 
Lumpi has also applied the alkyne-azide cycloaddition as a means to prepare new molecular 
materials, in this case nonlinear optic materials (NLOs) derived from a central enyne scaffold.
257
 
The majority of structures were formed using CuAAC, but one compound was prepared via 
microwave-assisted RuAAC using [Cp*RuCl]4 as the catalyst (Scheme 59). X-Ray diffraction 
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showed that this compound crystallized in an enantiomorphic space group, and displayed slightly 
improved nonlinear susceptibility in comparison to the corresponding 1,4-disubstituted isomer. 
Scheme 59.  A 1,5-disubstituted triazole for novel nonlinear optical materials
257
  
 
Dihydrazulenes (DHAs) can act as molecular photoswitches, where irradiation triggers a ring-
opening to form a vinylheptafulvalene, which can then thermally return to the original structure. 
This feature could for instance be exploited in molecular electronics. Nielsen studied the effect 
on that appending a triazole onto the benzene ring of the dihydroazulene had on this 
isomerization process.
258
 Compound 155 as well as its meta isomer were prepared via microwave 
assisted RuAAC (Scheme 60). Despite attempts to optimize the reaction, the yields were rather 
low. The rate of ring closure of these reactions was then measured and employed to determine 
the Hammett substituent constants for the meta- and para-tolyl isomers, as well as for the 
corresponding 1,4-disubstituted triazoles.  
Scheme 60. Triazolyl-dihydroazulenes as molecular photoswitches
258
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8. POLYMERS 
CuAAC has found many applications in the area of polymer chemistry and has generally been 
employed for either ‘clicking’ a molecule onto a polymeric scaffold derivatized with an alkyne 
or azide, or employing the 1,3-cycloaddition for constructing the polymer itself.
259
 In comparison 
with the field of medicinal chemistry, RuAAC has as yet been rather sparingly used in a polymer 
context, but examples include the synthesis of triazole-containing monomers, polymers and 
dendrimers using RuAAC, as well as polymer functionalization. 
 
8.1.  Triazole Monomers for Polymerization 
Nulwala and Hawker compared the behavior of 1,4- and 1,5-disubstituted vinyl triazoles 156 and 
157 in living free radical polymerization (Scheme 61).
260
 Monomers 156 were prepared in good 
yields by applying CuAAC to homopropargylic alcohol, followed by mesylation and elimination 
to introduce the vinyl functionality. While Fokin has reported successful RuAAC reactions with 
hindered propargylic alcohols,
12,27
 Nulwala and co-workers found homopropargylic alcohol to be 
a problematic substrate in this ruthenium-catalyzed reaction, and low yields of the triazole were 
obtained. Catalyst deactivation by the substrate was stated as the likely cause. By mesylating the 
alcohol before the RuAAC reaction, this problem was solved and vinyl triazoles 157 were 
prepared in reasonable yields. Both monomer types were subsequently polymerized using two 
different methods, i.e. Reversible Addition/Fragmentation Chain Transfer (RAFT) 
polymerization affording homopolymers, and Nitroxide-Mediated Polymerization (NMP) 
producing block polymers. As a general trend, the 1,5-isomer produced polymers with a higher 
glass transition temperature and lower solubility than their 1,4-isomeric counterparts, indicating 
a more rigid structure. In a later study, the co-polymerization of some of these monomers with 
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styrene was also explored, with the RuAAC-derived monomers showing a higher reactivity than 
the 1,4-isomers in this case.
261
  
Scheme 61. Synthesis of vinyl triazole monomers for polymerization
260
 
 
A sequential one-pot click-elimination procedure to access the same class of monomers has been 
reported by Blache, starting from 4-bromobutyne and using sodium hydroxide in water to effect 
the elimination to a vinyl functionality in the final step.
262
 Hua has also reported the synthesis of 
vinyl 1,4-disubsituted triazoles, this time under acidic conditions.
263
 Using a bimetallic catalyst 
system consisting of CuCl and RuCl3·H2O, propargylic alcohols were reacted with alkyl, aryl 
and benzyl azides and subsequently dehydrated in situ by trifluoroacetic acid present in the 
reaction mixture. Each of the two catalysts could be used separately, but the bimetallic catalyst 
increased the yield substantially. Bielawski constructed polymer initiators containing 1,4- and 
1,5-triazole isomers, and subsequently grew poly(methyl acrylate) chains from these structures in 
order to study the mechanical properties of the formed polymers.
264
 Ultrasound irradiation of 
these structures in acetonitrile resulted in a cycloreversion to the starting azide and alkyne, with a 
faster reaction rate for the 1,5-isomer in comparison to the 1,4-derivative. A theoretical study of 
the cycloreversion of 1,4- and 1,5-disubstituted 1,2,3-triazoles has also been reported by 
Blank.
265
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8.2.  Polymerization via RuAAC 
The azide alkyne cycloaddition reaction can be employed as a method of polymerization itself, 
by linking monomers functionalized with azide and alkyne units. While this technique has been 
extensively applied using CuAAC,
259
 there are as yet few examples of this type of application 
employing RuAAC.
266
 Storey and co-workers compared the regioselectivity in the reaction of a 
diazide-functionalized derivative of bisphenol A (158) with a dialkyne-substituted 
tetraethyleneglycol derivative (159) using thermal cycloadditions as well as CuAAC and 
RuAAC (Scheme 62).
267
 While the copper-catalyzed click reaction could be performed under 
neat conditions with only the two monomers present, the solubility of Cp*RuCl(COD) in this 
bulk system at 70 °C was not sufficient and a thermal, non-regioselective reaction was observed 
instead. However, solution-phase polymerization with the same catalyst in refluxing THF 
afforded the desired polymer with a 94:6 selectivity for the 1,5-disubstituted triazole compared to 
the 1,4-isomer. 
Scheme 62. RuAAC-polymerization of a bisphenol-A derivative
267
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In another example, Brady employed RuAAC to construct polymers containing Mo-Mo bonds, 
where the sensitivity of these metal-metal bonds constitutes a problem when conventional 
polymerization techniques are employed.
268
 Building block 160 was first reacted with benzyl 
azide and with 1,4-bis(azidomethyl)benzene (161) in model reactions (Fig. 33). Employing 
Cp*Ru(PPh3)2Cl as the catalyst, complete reaction was attained after 4 hours. Reactions with 
diazide-functionalized polystyrene and polyethylene glycol oligomers (162 and 163) were then 
pursued with good results, affording polymeric structures with the Mo-Mo bond still intact 
according to analysis of the C≡O bond in IR. 
Figure 33. Polymerization of Mo-containing building blocks using RuAAC
268
 
 
 
8.3.  Polymer Functionalization 
Fokin and co-workers have prepared halo-substituted triazoles using ruthenium catalysis, 
described in detail in section 4.4.3.
91
 Included in this study was also an example of RuAAC 
involving a soluble non-crosslinked functionalized polystyrene resin. Polymer 164, with 7% of 
the backbone carrying a pendant azide unit, was reacted with an excess of bromoalkyne 165, 
affording the bromotriazole-derivatized resin 166 (Scheme 63). IR analysis of the final polymer 
verified that the azide stretch had indeed disappeared and 
1
H NMR confirmed the presence of the 
amide methyl groups. 
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Scheme 63. Functionalization of a soluble polystyrene resin via RuAAC
91
 
 
Pola has explored the attachment of peptides to polymeric drug carriers using RuAAC.
269-270
 
Azide-terminated peptides were reacted with an aminopropargyl-functionalized co-polymer of 
N-(2-hydroxypropyl)methacrylamide (HPMA) bearing the anticancer drug doxorubicin. The 
choice of catalyst was found to be important here. In a test reaction between 5-azidopentanoic 
acid and the alkyne-functionalized polymer, using Cp*RuCl(PPh3)2 as catalyst at 60 °C afforded 
only 25% of the polymer conjugate after 12 hours. By switching to Cp*RuCl(COD), which can 
be employed at ambient temperature,
27
 full conversion was attained after 6 hours, however, and 
this catalyst was subsequently used for the conjugation reactions. 
 
8.4.  Hyperbranched Structures 
Tang
271
 and Brady
272
 have both targeted dendritic polytriazole structures via RuAAC. Tang 
employed amine-centered triyne 167, combining this with diazides of different chain lengths, 
while Brady selected 1,3,5-triethynylbenzene (168) as the central core for appending metal-
containing building blocks, similar in structure to those described in section 8.2 (Fig. 34). Tang 
and co-workers found that Cp*Ru(PPh3)2Cl, and also the Ru(III) oligomer [Cp*RuCl2]n, could be 
employed in the coupling of 167 with diazides to produce the desired hyperbranched triazoles in 
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good yields. The degree of branching was determined using 
1
H NMR, and the ability of the 
polymers to form films as well as the photophysical properties of these films was also studied. 
Brady’s attempted coupling of 168 with 169 was unsuccessful, however, affording instead a 
polymer devoid of molybdenum. The authors propose that a competing cyclotrimerization 
reaction, not involving 169, is taking place instead. 
Figure 34. Building blocks for the formation of dendritic polytriazoles 
 
 
9. OTHER METHODS FOR THE FORMATION OF 1,5-DISUBSTITUTED 1,2,3-
TRIAZOLES 
The use of other metals than Ru and Cu in cycloaddition reactions to form triazoles reaction has 
been recently reviewed by Astruc,
21
 and will be only very briefly mentioned here. Iridium can 
catalyze the reactions of bromoalkynes with organic azides to 1,5-isomers with a 4-bromo 
substituent,
273
 as well as to effect the cyclization of internal thioalkynes.
274
 Wang et al reported 
that cerium could be applied to access 1,5-disubstituted 1,2,3-triazoles, in this case employing a 
nitroolefin instead of an alkyne together with benzyl or phenyl azide.
275
 Ytterbium has been 
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applied in one-pot cascade reactions, affording fused 1,4,5-substitued triazoles,
276
 and samarium-
catalyzed reactions are have been reported to cyclize terminal alkynes with azides to provide the 
1,5-isomer. Iron can effect the cyclization of chalcones with sodium azide but affords the 2,4,5-
trisubstuted 1,2,3-triazole product.
277
 Koguchi employed a copper catalyst in ionic liquids in a 
method that initially affords the 1,4-isomer with a protecting group in the 4-position.
278
 This 
triazole is subsequently alkylated on the 5-position and deprotected to finally afford the 1,5-
isomer. Lautens used a combination of Cu and Pd in a tandem reaction to form 1,4,5-
trisubstituted triazoles,
279
 while Greaney has reported a Zn-mediated synthesis of 1,5- and 1,4,5-
isomers.
280
 
1,5-Disubstituted 1,2,3-triazoles can also be formed without the use of a metal. These 
methods have the advantage that an azide is not necessarily involved, and azide-free methods for 
1,2,3-triazole formation has been recently highlighted.
281
 A feature article by Dehean 
summarizes the use of organocatalysis for the formation of substituted 1,2,3-triazoles and only a 
few examples will be mentioned here.
282
 Azide-free multicomponent reactions have been 
applied, for instance Wan describes the use enaminones with primary amines and tosylhydrazine 
in the presence of I2,
283
 Heating to 110 °C in DMSO afforded triazoles functionalized with an 
aldehyde or ketone in the 5-position. Another three-component method, albeit not azide free, has 
been reported by Pathak and uses vinyl sulfones in conjunction with alkyl halides and sodium 
azide.
284
 The same group also reports the use of selenium to access 1,4,5-trisubstituted 1,2,3-
triazoles.
285
 Fokin has also reported a robust method for the reaction of aryl azides with terminal 
aryl alkynes in the presence of catalytic amounts of tetramethylammonium hydroxide at room 
temperature, affording 1,5-diarylsubstituted 1,2,3-triazoles in good yields.
286
 For a full survey of 
triazole synthesis without employing ruthenium, we refer to the aforementioned reviews. 
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10. CONCLUSIONS AND FUTURE OUTLOOK 
The ruthenium-catalyzed azide alkyne cycloaddition (RuAAC) provides direct access to 1,5-
disubstituted 1,2,3-triazoles, and acts as a counterpart to the copper-catalyzed ‘click’ reaction 
where the 1,4-isomer of the triazole is formed. Many Ru(II)-complexes catalyze the reaction, but 
a pentamethylcyclopentadienyl (Cp*) ligand as well as chloride bonded to ruthenium are 
generally required to attain good regioselectivity. Mechanistic studies indicate a different 
pathway for RuAAC compared to CuAAC, and this is further substantiated by the fact that 
internal alkynes can be employed in the Ru-catalyzed reaction which is not the case for CuAAC. 
Further advantages of RuAAC include the 1,5-disubstitution pattern that can be exploited for 
instance in the formation of macrocycles, where the regiochemistry in the RuAAC reaction is 
better suited for smaller rings than the 1,4-pattern obtained in CuAAC. The CuAAC reaction, 
however, has the benefit of using a less expensive catalyst and can generally be performed at a 
lower temperature than RuAAC.  Both reactions are compatible with a wide range of functional 
groups, however. 
  One can easily realize the potential and usefulness of 1,5-triazoles in all the various fields of 
medicinal chemistry and biochemistry, both as tools as well as inhibitors, and the RuAAC 
reaction has found more widespread use among medicinal chemists than in any other area of 
research. However, a derivative prepared via RuAAC for clinical purposes has yet to appear in a 
drug on the market. Evaluation of the 1,5-disubstituted triazoles as peptide bond or disulfide 
mimetics, or as -helix mimetics is also of interest and several studies in this area have been 
reported. Other areas of chemistry are surprisingly underdeveloped in terms of applying the 
RuAAC reaction, and there is ample scope for further work in many fields, including the 
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development of new materials and electronic devices, as well as the use of 1,5-disubstutited 
triazoles as ligands in coordination chemistry and catalysis. A commercially available polymer-
supported catalyst of RuAAC could also be of interest. We envisage many new examples of 
RuAAC-applications in the future. 
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AAC   azide alkyne cycloaddition 
AAS  atomic absorption spectroscopy 
Ad  adamantyl 
ADRT  4’-azidothymidine 
AMPA  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
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AZT  3’-azidothymidine 
Boc  tert-butoxycarbonyl 
BTD  benzothiadiazole 
BOP  (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 
CA  carbonic anhydrase 
CBS  complete basis set 
CMT  chloromethyl triazole 
COD  cyclooctadiene 
COX  cyclooxygenase 
Cp  cyclopentadienyl 
Cp*  pentamethylcyclopentadienyl 
CPE  cytopathic effect 
CuAAC Cu-catalyzed azide alkyne cycloaddition 
Cy  cyclohexyl 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCE  dichloroethane 
DFT  density functional theory 
DHA  dihydroazulene 
DMA  dimethylacetamide 
DOS  diversity-oriented synthesis 
dppp  1,3-bis(diphenylphosphine)propane 
dUTP  2’-deoxyuridine 5’-triphosphate 
EDC  1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
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ER  endoplasmic reticulum 
FDA  food and drug administration 
Fmoc  fluorenylmethoxycarbonyl 
FU  fluorouracil 
GHK  Gly-His-Lys 
GIAO  gauge-independent atomic orbitals 
GNR  gold nanorod 
GPRC  G-protein coupled receptor 
HATU  1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 
3-oxid hexafluorophosphate 
hCA  human carbonic anhydrase 
HDAC  histone deacetylase 
HHK  histone H4 histidine kinase 
HIV  human immunodeficiency virus 
HMBC heteronuclear multiple-bond correlation spectroscopy 
HPMA  N-(2-hydroxypropyl)methacrylamide 
HOBt  1-hydroxybenzotriazole 
HOAt  1-hydroxy-7-azobenzotriazole 
HSP  heat shock protein 
IRAP  insulin-regulated aminopeptidase 
ITC  isothermal titration calorimetry 
L  ligand 
LDA  lithium diisopropylamide 
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LED  light-emitting diode 
NBD  norbornadiene 
NCI  National Cancer Institute 
NHC  N-heterocyclic carbene 
NOE  nuclear Overhauser effect 
NP  nanoparticle 
MD  molecular dynamics 
MM  molecular mechanics 
NiSOD nickel superoxide dismutase 
NLO  nonlinear optical material 
NMP  nitroxide-mediate polymerization 
PDB  protein data bank 
PEG  polyethylene glycol 
phen  1,10-phenanthroline 
pHis  phosphohistidine 
POM  pivaloyloxymethyl 
PPI  protein-protein interaction 
ppy  phenylpyridine 
pTza  phosphotriazolylalanine 
QM  quantum mechanics 
RAFT  reversible addition-fragmentation chain transfer 
Rnase A bovine pancreatic ribonuclease 
RuAAC Ru-catalyzed azide alkyne cycloaddition 
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SPPS  solid phase peptide synthesis 
SPS  solid phase synthesis 
STFI  sunflower trypsin inhibitor 
Su  succinimidyl 
TBAF  tetra-n-butylammonium fluoride 
TFA  trifluoroacetic acid 
Tp  trispyrazolylborate 
Trt  triphenylmethyl (trityl) 
Ts  p-toluenesulfonyl 
TTF  tetrathiafulvalene 
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